Introduction {#s1}
============

Cells that migrate as collectives help establish and organize many tissues and organs in the embryo, yet also promote tumor invasion, dissemination and metastasis ([@bib23]; [@bib24]; [@bib93]; [@bib12]; [@bib77]). A wide variety of cells undergo collective cell migration during development, ranging from neural crest cells in *Xenopus*, the zebrafish lateral line primordium, and branching mammary glands ([@bib24]; [@bib77]; [@bib33]; [@bib80]), among many other examples. Despite the apparent diversity in collectively migrating cell types, there is remarkable conservation of the cellular and molecular mechanisms that underlie group cell movements. In particular, migrating collectives require fine-tuned organization and cell coordination to move effectively as a unified group. Similar to individually migrating cells, collectively migrating cells display a front-rear polarity, but this polarity is often organized at the group level ([@bib46]). Leader cells at the front extend characteristic protrusions that help collectives navigate tissues. Mechanical cell coupling and biochemical signals then reinforce collective polarity by actively repressing protrusions from follower cells and by maintaining lead cell protrusions that pull the group forward ([@bib46]; [@bib25]). Importantly, cell-cell adhesions keep collectives together by maintaining strong but flexible connections between cells. Moreover, many cell collectives exhibit a 'supracellular' organization of the cytoskeleton at the outer perimeter of the entire cell group that serves to further coordinate multicellular movement ([@bib80]; [@bib79]; [@bib31]; [@bib70]). Despite progress in understanding how single cells become polarized and motile, less is known about the mechanisms that control the global organization, cohesion, and coordination of cells in migrating collectives.

*Drosophila* border cells are a genetically tractable and relatively simple model well-suited to investigate how cell collectives undergo polarized and cooperative migration within a developing tissue ([@bib56]; [@bib73]). The *Drosophila* ovary is composed of strings of ovarioles made up of developing egg chambers, the functional unit of the *Drosophila* ovary. During late oogenesis, four to eight follicle cells are specified at the anterior end of the egg chamber to become migratory border cells. The border cells then surround a specialized pair of follicle cells, the polar cells, and delaminate as a multicellular cluster from the follicular epithelium. Subsequently, the border cell cluster undergoes a stereotyped collective migration, moving between 15 large germline-derived nurse cells to eventually reach the oocyte at the posterior end of the egg chamber ([Figure 1A--F](#fig1){ref-type="fig"}). Throughout migration, individual border cells maintain contacts with each other and with the central polar cells so that all cells move as a single cohesive unit ([@bib42]; [@bib8]). A leader cell at the front extends a migratory protrusion whereas protrusions are suppressed in trailing follower cells ([@bib64]; [@bib5]; [@bib63]). As with other collectives, polarization of the border cell cluster is critical for the ability to move together and in the correct direction, in this case towards the oocyte ([Figure 1A--F](#fig1){ref-type="fig"}; [@bib64]; [@bib5]).

![NiPp1 expression causes the border cell cluster to fall apart and disrupts migration.\
(**A--F**) Wild-type border cell migration during oogenesis stages 9 and 10. (**A--C**) Egg chambers at the indicated stages labeled with E-Cadherin (E-Cad; green), F-actin (magenta) and DAPI (blue). Arrowheads indicate the border cell cluster. (**D--F**) Magnified views of the same border cell cluster from (**A--C**), showing FasIII (red) in the polar cells, E-Cad and DAPI. The border cell cluster is composed of two polar cells (marked by asterisks) in the center and four to eight outer border cells that are tightly connected with each other as indicated by E-Cad staining. (**G, H**) Egg chambers labeled with Singed (SN; green) to detect border cells (arrowheads), phalloidin to detect F-actin (red), and DAPI to detect nuclei (blue). Control border cells (**G**) reach the oocyte as a single cluster, whereas NiPp1-expressing border cells (**H**) dissociate from the cluster into small groups, with only a few reaching the oocyte. (**I**) Quantification of border cell cluster migration for matched control and NiPp1 overexpression, shown as the percentage that did not complete (red), or completed (green) their migration to the oocyte, as indicated in the egg chamber schematic. (**J**) Quantification of cluster cohesion, shown as the percentage of border cells found as a single unit (one part) or split into multiple parts (2--3 parts or \>3 parts) in control versus NiPp1-expressing egg chambers. (**I, J**) Error bars represent SEM in three experiments, each trial assayed n ≥ 69 egg chambers (total n ≥ 221 egg chambers per genotype). \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. (**K--L''**) Frames from a control ([Video 1](#video1){ref-type="video"}; **K--K"**) and an NiPp1 overexpression (OE; [Video 2](#video2){ref-type="video"}; **L--L"**) time-lapse video showing movement of the border cell cluster over the course of 3 hr (time in minutes). Border cells (arrowheads) express UAS-mCherry-Jupiter, which labels cytoplasmic microtubules. (**M**) Measurement of border cell migration speed from control (n = 11 videos) and NiPp1 overexpression (n = 11 videos; 22 tracked border cell 'parts') videos, shown as a box-and-whiskers plot. The whiskers represent the minimum and maximum; the box extends from the 25th to the 75th percentiles and the line indicates the median. \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. In this and all subsequent figures, anterior is to the left and the scale bars indicate the image magnification. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig1){#fig1}

Polarization of the border cell cluster begins when two receptor tyrosine kinases (RTKs) expressed by border cells, PDGF- and VEGF-receptor related (PVR) and Epidermal Growth Factor Receptor (EGFR), respond to multiple growth factors secreted from the oocyte ([@bib19]; [@bib47]). Signaling through PVR/EGFR increases activation of the small GTPase Rac, triggering F-actin polymerization and formation of a major protrusion in the lead border cell ([@bib64]; [@bib63]; [@bib19]; [@bib92]). E-Cadherin-based adhesion to the nurse cell substrate stabilizes this lead cell protrusion via a feedback loop with Rac ([@bib8]). Furthermore, the endocytic protein Rab11 and the actin-binding protein Moesin mediate communication between border cells to restrict Rac activation to the lead cell ([@bib67]). Mechanical coupling of border cells through E-Cadherin suppresses protrusions in follower cells, both at cluster exterior surfaces but also between border cells and at contacts with polar cells ([@bib56]; [@bib8]). E-Cadherin also maintains border cell attachment to the central polar cells. F-actin and non-muscle myosin II (Myo-II) are enriched at the outer edges of the border cell cluster ([@bib3]; [@bib43]; [@bib14]). Such 'inside-outside' polarity contributes to the overall cluster shape, cell-cell organization, and coordinated motility of all border cells ([@bib56]). While progress has been made in understanding the establishment of front-rear polarity, much less is known about how individual border cell behaviors are fine-tuned and adjusted to produce coordinated and cooperative movement of the cluster as an entire unit.

In the current study we made the unexpected discovery that Protein phosphatase 1 (Pp1) activity coordinates the collective behavior of individual border cells. Dynamic cycles of protein phosphorylation and dephosphorylation precisely control many signaling, adhesion and cytoskeletal pathways required for cell migration ([@bib39]). Serine-threonine kinases, such as Par-1, Jun kinase (JNK), and the p21-activated kinase Pak3, as well as phosphorylated substrate proteins such as the Myo-II regulatory light chain (MRLC; *Drosophila* Spaghetti squash, Sqh) and Moesin regulate different aspects of border cell migration ([@bib42]; [@bib67]; [@bib44]; [@bib21]). In contrast, the serine-threonine phosphatases that counteract these and other kinases and phosphorylation events have not been extensively studied, either in border cells or in other cell collectives. Pp1 is a highly conserved and ubiquitous serine-threonine phosphatase found in all eukaryotic cells ([@bib41]; [@bib90]). Pp1 can directly dephosphorylate substrates in vitro, but specificity for phosphorylated substrates in vivo is generally conferred by a large number of regulatory subunits (also called Pp1-interacting proteins \[PIPs\]). These regulatory subunits form functional Pp1 complexes through binding to the Pp1 catalytic (Pp1c) subunits and mediate the recruitment of, or increase the affinity for, particular substrates ([@bib90]; [@bib30]). Thus, despite the potential for pleiotropy, Pp1 complexes have specific and precise cellular functions in vivo, that range from regulation of protein synthesis, cell division and apoptosis to individual cell migration ([@bib10]; [@bib22]).

We now show that Pp1 activity controls multiple collective behaviors of border cells, including timely delamination from the epithelium, collective polarization, cohesion, cell-cell coordination, and migration. Remarkably, Pp1-inhibited border cells round up, break off from the main group, and move as single cells or small groups but are generally unable to complete their migration. We determine that Pp1 controls the levels of E-Cadherin and β-Catenin, which are needed to retain border cells within a cohesive cluster. Additionally, Pp1 activity restricts F-actin and Myo-II enrichment to the outer edges of the cluster, maintaining a supracellular cytoskeletal ultrastructure and supporting polarized collective movement. Furthermore, a major Pp1 specific complex for Myo-II activity, myosin phosphatase, coordinates border cell shape and adherence of cells to the cluster. Our work thus identifies Pp1 activity, mediated through distinctive phosphatase complexes such as myosin phosphatase, as a critical molecular regulator of collective cell versus single cell behaviors in a developmentally migrating collective.

Results {#s2}
=======

NiPp1 blocks border cell collective movement and cohesion in vivo {#s2-1}
-----------------------------------------------------------------

To address the role of phosphatases in border cell migration, we carried out a small-scale genetic screen to inhibit selected serine-threonine phosphatases that are expressed during oogenesis using RNAi as well as a protein inhibitor that targets Pp1 catalytic subunits ([Table 1](#table1){ref-type="table"}; [@bib53]; [@bib4]). We drove expression of RNAi and the inhibitor using *c306-*GAL4, an early anterior follicle cell driver expressed at high levels in border cells and polar cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Inhibition of *Pp4-19C* (one RNAi line) and Pp1c, through overexpression of Nuclear inhibitor of Protein phosphatase 1 (NiPp1), significantly disrupted border cell migration ([Table 1](#table1){ref-type="table"}). NiPp1 is an endogenous protein that when overexpressed, effectively and specifically blocks Pp1 catalytic subunit activity in vivo ([@bib4]; [@bib96]; [@bib61]; [@bib89]). Pp1 and associated complexes are important phosphatase regulators of many cellular processes. Moreover, females expressing NiPp1 driven by *c306*-GAL4 did not produce adult progeny when crossed to wild-type males, consistent with infertility and suggesting a role for Pp1 in normal oogenesis ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Here we focused on further elucidating the function of Pp1 in border cells.

###### Summary of the PPP family screen.

Results of the targeted serine-threonine protein phosphatase RNAi screen.

  ----------------------------------------------------------------------------------------------------
  Gene symbol   Annotation symbol   RNAi line    Migration defect (c306-Gal4)   Expression level in\
                                                                                ovary (modENCODE)
  ------------- ------------------- ------------ ------------------------------ ----------------------
  *Pp2B-14D*    CG9842              BDSC:25929   No                             moderate

                                    BDSC:40872   No                             

                                    VDRC:46873   No                             

  *mts*         CG7109              BDSC:27723   Pupal lethal                   moderate

                                    BDSC:38337   No                             

                                    BDSC:57034   No                             

                                    BDSC:60342   No                             

  *Pp4-19C*     CG32505             BDSC:27726   Pupal lethal                   moderate

                                    BDSC:38372   No                             

                                    BDSC:57823   Pupal lethal                   

                                    VDRC:25317   Yes                            

  *CanA-14F*    CG9819              BDSC:38966   No                             moderate

  *PpD3*        CG8402              BDSC:57307   No                             moderate

  *PpV*         CG12217             BDSC:57765   No                             moderate

  *NiPp1*       CG8980              BDSC:23711   Yes                            moderate

  *CanA1*       CG1455              BDSC:25850   No                             low

  *CG11597*     CG11597             BDSC:57047   No                             very low

                                    BDSC:61988   No                             

  *rgdC*        CG44746             BDSC:60076   No                             very low
  ----------------------------------------------------------------------------------------------------

###### Genotypes for figures.

List of genotypes shown in the figures.

  Figure                                                                        Panel                                                                                                   Genotype
  ----------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------
  [Figure 1](#fig1){ref-type="fig"}                                             A-F                                                                                                     *w1118*
  G                                                                             *c306*-GAL4,tsGAL80/+                                                                                   
  H                                                                             *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/+                                                                     
  K                                                                             *c306*-GAL4/+; *UAS*-Cherry:Jupiter / +                                                                 
  L                                                                             *c306-*GAL4*/+; UAS-*Cherry:Jupiter */ +;UAS-*NiPp1*/+*                                                 
  [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}                     A                                                                                                       *c306*-GAL4,tsGAL80/+;*UAS*-GFP.nls/+
  B                                                                             *slbo*-GAL4/+;*UAS*-GFP.nls/+                                                                           
  [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}                     B                                                                                                       *c306-*GAL4*/+;UAS-*PLCdelta-PH-EGFP/+
  D-G                                                                           *slbo*-GAL4,*UAS*-mCD8-GFP/+;                                                                           
  *slbo*-GAL4,*UAS*-mCD8-GFP/+;*UAS*-NiPp1/+                                                                                                                                            
  H-K                                                                           *upd*-GAL4/+;*UAS*-mCD8.ChRFP/+                                                                         
  *upd*-GAL4/+;*UAS*-NiPp1/+                                                                                                                                                            
  L-N                                                                           *c306*-GAL4,tsGAL80/+                                                                                   
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/+                                                                                                                                                   
  [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}                     A                                                                                                       *c306-*GAL4*/*+ (WT)
  B                                                                             *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/+                                                                     
  [Figure 2](#fig2){ref-type="fig"}                                             A-C                                                                                                     FlyFos021765(pRedFlp-Hgr) (Pp1alpha-96A15346::2XTY1-SGFP-V5-preTEV-BLRP-3XFLAG)dFRT
  D-F                                                                           w\[1118\] PBac{681 .P.FSVS-1}flw\[CPTI002264\]                                                          
  G-H                                                                           *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/*UAS*-mCD8.ChRFP                                                      
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/*UAS*-Pp1α−96A.HA                                                                                                                                   
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/*UAS*-Pp1-87B.HA                                                                                                                                    
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/*UAS*-Pp1-13C.HA                                                                                                                                    
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/*UAS*-Flw.3xHA                                                                                                                                      
  *c306*-GAL4,tsGAL80/+;*UAS*-hPPP1CC/+;*UAS*-NiPp1/                                                                                                                                    
  [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}                     A                                                                                                       *c306-GAL4/+;UAS-*Pp1α−96A.HA/+
  B                                                                             *c306-GAL4/+;UAS-*Pp1-87B.HA/+                                                                          
  C                                                                             *c306-GAL4/+;UAS-*Pp1-13C.HA/+                                                                          
  D                                                                             *c306-GAL4/+;UAS-*Flw.3xHA/+                                                                            
  E                                                                             *c306-GAL4/+;UAS-*hPPP1CC/+                                                                             
  F-K                                                                           Same as [Figure 2](#fig2){ref-type="fig"}. G-H                                                          
  [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}                     A                                                                                                       *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/+
  B                                                                             *slbo*-GAL4/+;*UAS*-NiPp1/Pp1alpha-96A-GFP                                                              
  C                                                                             w1118/Flw-YFP;*slbo*-GAL4/+;*UAS*-NiPp1/+                                                               
  [Figure 3](#fig3){ref-type="fig"}                                             A-D                                                                                                     *c306*-GAL4/+;*UAS-mCherry RNAi*/+
  *c306*-GAL4/+;*UAS-Pp1α−96A RNAi*/+                                                                                                                                                   
  *c306-*GAL4*/+;UAS-Pp1-87B RNAi /+*                                                                                                                                                   
  *c306-*GAL4*/+;UAS-Pp1-13C RNAi/+*                                                                                                                                                    
  G                                                                             *c306*-GAL4,tsGAL80/+;*UAS*-mCherry RNAi/*UAS*-PLCdelta-PH-EGFP                                         
  *c306-GAL4,tsGAL80/+;UAS-Pp1α−96A RNAi/+;UAS-*PLCdelta-PH-EGFP*/+*                                                                                                                    
  *c306-GAL4,tsGAL80/+;UAS-Pp1-87B RNAi /+;UAS-*PLCdelta-PH-EGFP*/+*                                                                                                                    
  *c306-GAL4,tsGAL80/+;UAS-Pp1-13C RNAi/+;UAS-*PLCdelta-PH-EGFP*/+*                                                                                                                     
  H-H\'\'                                                                       *P{w\[+mC\]=Ubi mRFP.nls}1, w\[\*\], P{ry\[+t7.2\]=hsFLP}12 P{ry\[+t7.2\]=neoFRT}19A/flwFP41 FRT 19A*   
  [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}                     A                                                                                                       Same as [Figure 3](#fig3){ref-type="fig"}. G
  B                                                                             *P{w\[+mC\]=Ubi mRFP.nls}1, w\[\*\], P{ry\[+t7.2\]=hsFLP}12 P{ry\[+t7.2\]=neoFRT}19A/flwFP41 FRT 19A*   
  [Figure 4](#fig4){ref-type="fig"}                                             A-J                                                                                                     *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/+*
  *c306*-GAL4,tsGAL80/+;*UAS-E-cad RNAi (VDRC:103962)/+*                                                                                                                                
  *c306*-GAL4,tsGAL80/+;*UAS-E-cad RNAi (VDRC:27082)/+*                                                                                                                                 
  *c306*-GAL4,tsGAL80/+;*UAS-β-Cat RNAi (VDRC:107344)/+*                                                                                                                                
  *c306*-GAL4,tsGAL80/+;*UAS-β-Cat RNAi (VDRC:31305)/+*                                                                                                                                 
  *c306*-GAL4,tsGAL80/+;*UAS-α-Cat RNAi (VDRC:107298)/+*                                                                                                                                
  *c306*-GAL4,tsGAL80/+;*UAS-α-Cat RNAi (VDRC:20123)/+*                                                                                                                                 
  K-P                                                                           *w1118(control)*                                                                                        
  *c306*-GAL4,tsGAL80/+;*UAS*-NiPp1/+                                                                                                                                                   
  [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}                     A,C,E,G                                                                                                 *c306*-GAL4/+;*UAS-mCherry RNAi/+*
  B                                                                             *c306*-GAL4/+;*UAS-E-cad RNAi (VDRC:103962)/+*                                                          
  D                                                                             *c306*-GAL4/+;*UAS-β-Cat RNAi (VDRC:107344)/+*                                                          
  F                                                                             *c306*-GAL4/+;*UAS-α-Cat RNAi (VDRC:107298)/+*                                                          
  G                                                                             *c306*-GAL4/+;*UAS-β-Cat RNAi (BDSC:31305)/+*                                                           
  I-J                                                                           *c306*-GAL4/+;*UAS-mCherry RNAi/+*                                                                      
  *upd*-GAL4,tsGAL80/+;*UAS-α-Cat RNAi (VDRC:107298)/+*                                                                                                                                 
  *upd*-GAL4/+;*UAS-α-Cat RNAi (VDRC:20123)/+*                                                                                                                                          
  [Figure 5](#fig5){ref-type="fig"}                                             A                                                                                                       *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/UAS*-PLCdelta-PH-EGFP
  B                                                                             *c306-*GAL4*,tsGAL80/+;UAS-Pp1α−96A RNAi/+;UAS-P*LCdelta-PH-EGFP/+                                      
  C-F                                                                           Same as [Figure 3](#fig3){ref-type="fig"}. G                                                            
  [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}                     B-C                                                                                                     Same as [Figure 3](#fig3){ref-type="fig"}. G
  D-E                                                                           yw; *slbo*-GAL4/*UAS*-Rac FRET (WT) and *slbo*-GAL4/*UAS*-Rac FRET; +/*UAS*-NiPp1                       
  F-J                                                                           *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/UAS*-PLCdelta-PH-EGFP                                           
  *c306-*GAL4*,tsGAL80/+;UAS-α-Cat RNAi (VDRC:107298);UAS-P*LCdelta-PH-EGFP/+                                                                                                           
  [Figure 6](#fig6){ref-type="fig"}                                             A                                                                                                       *slbo*-GAL4/+;*UAS*-PLCdelta-PH-EGFP/+
  B                                                                             *slbo-*GAL4*/+;UAS-NiPp1/UAS-*PLCdelta-PH-EGFP                                                          
  D,F                                                                           *w1118 (control)*                                                                                       
  E,G                                                                           *slbo*-GAL4/+;*UAS*-NiPp1/+                                                                             
  H                                                                             *c306-GAL4,tsGAL80*/+;+/sqh-GFP (VDRC:318484)                                                           
  I                                                                             *c306-GAL4,tsGAL80*/+;*UAS*-NiPp1/sqh-GFP (VDRC:318484)                                                 
  [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}                     A                                                                                                       Same as [Figure 6](#fig6){ref-type="fig"}. H
  B                                                                             Same as [Figure 6](#fig6){ref-type="fig"}. I                                                            
  [Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}                     A,A\',E,I                                                                                               *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/+*
  B,B\',F,J                                                                     *c306*-GAL4,tsGAL80/+;*UAS-E-cad RNAi (VDRC:103962)/+*                                                  
  C,C\',G,K                                                                     *c306*-GAL4/+;*UAS-β-Cat RNAi (BDSC:31305)/+*                                                           
  D,D\',H                                                                       *c306*-GAL4,tsGAL80/+;*UAS-sqh RNAi (VDRC:7916)/+*                                                      
  [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}                     A,C                                                                                                     *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/+*
  B,D                                                                           *c306*-GAL4,tsGAL80/+;*UAS-sqh RNAi (VDRC:7916)/+*                                                      
  [Figure 7](#fig7){ref-type="fig"}                                             A-A\'                                                                                                   *c306*-GAL4,tsGAL80/+;*UAS*-PLCdelta-PH-EGFP/+
  B-B\'                                                                         *c306*-GAL4,tsGAL80/+;*UAS*-PLCdelta-PH-EGFP/UAS-NiPp1                                                  
  D-H                                                                           *c306*-GAL4,tsGAL80/+;*UAS*-mCherry RNAi/+                                                              
  *c306*-GAL4,tsGAL80/+;*UAS*-Mbs RNAi/+                                                                                                                                                
  [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}                     D-F                                                                                                     *w1118*
  G-G\'\'                                                                       FlyFos021765(pRedFlp-Hgr) (Pp1alpha-96A15346::2XTY1-SGFP-V5-preTEV-BLRP-3XFLAG)dFRT                     
  I-I\'\'                                                                       w\[1118\] PBac{681 .P.FSVS-1}flw\[CPTI002264\]                                                          
  K                                                                             *c306*-GAL4,tsGAL80/+;*UAS-mCherry RNAi/+*                                                              
  L                                                                             *c306*-GAL4,tsGAL80/+;*UAS-Mbs RNAi/+*                                                                  
  [Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}                     A-A\'                                                                                                   *slbo*-GAL4/UAS-Rho FRET; +/*UAS*-Rho FRET
  B-B\'                                                                         *slbo*-GAL4/UAS-Rho FRET;*UAS*-NiPp1/*UAS*-Rho FRET                                                     

We used two GAL4 drivers to assess phenotypes, *c306-*GAL4 to determine early broad function of Pp1 in border cells and polar cells and *slbo-*GAL4 for later more restricted function in just border cells ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Expression of NiPp1 strongly disrupted both the ability of border cells to organize into a cohesive cluster and to migrate successfully ([Figure 1G--J](#fig1){ref-type="fig"}). Unlike control border cells, most NiPp1-expressing border cells failed to reach the oocyte by stage 10 (98%; [Figure 1I](#fig1){ref-type="fig"}). Importantly, NiPp1-expressing border cells were no longer found in one cohesive cluster. Instead, individual cells and smaller groups split off from the main cluster ([Figure 1H](#fig1){ref-type="fig"}). Whereas control border cells migrated as a single cohesive unit ('one part'), NiPp1-expressing border cells split into two to three (50%), or more (40%), parts ([Figure 1H,J](#fig1){ref-type="fig"}). Migration and cluster cohesion defects were observed when NiPp1 was expressed early in both border cells and the central polar cells (*c306*-GAL4; [Figure 1I,J](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}) or later in just border cells (*slbo*-GAL4; [Figure 1---figure supplement 2C--G](#fig1s2){ref-type="fig"}). Polar cells, through JAK/STAT signaling, recruit border cells to form a migratory cluster, and anchor border cells to the cluster ([@bib8]; [@bib27]; [@bib81]). Therefore, we tested the function of Pp1 in polar cells. We observed no defects in cohesion or migration when NiPp1 was expressed only in polar cells (*upd*-GAL4; [Figure 1---figure supplement 2C,H--K](#fig1s2){ref-type="fig"}). Fragmentation of clusters, however, was stronger when NiPp1 was driven by *c306*-GAL4 rather than *slbo*-GAL4 (compare [Figure 1J](#fig1){ref-type="fig"} to [Figure 1---figure supplement 2G](#fig1s2){ref-type="fig"}), possibly due to earlier and higher expression of c306-GAL4 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [@bib81]). Although polar cells are normally located at the center of the border cell cluster and maintain overall cluster organization ([@bib8]; [@bib57]), individual NiPp1-expressing border cells could completely separate from polar cells as well as the other border cells ([Figure 1---figure supplement 2L--N](#fig1s2){ref-type="fig"}). Finally, NiPp1 border cells appeared rounder than normal, indicating that individual cell shapes were altered (see below). Together, these results demonstrate that NiPp1 expression in border cells, but not polar cells alone, disrupts collective migration, cluster organization and adhesion.

Because very few border cells reached the oocyte, we investigated whether NiPp1-expressing border cells were correctly specified and functional. We first examined the expression of the transcription factor Slbo, the fly C/EBP homolog, which is required for border cell specification in response to JAK/STAT signaling ([@bib81]; [@bib55]). NiPp1-expressing border cells generally expressed Slbo, similarly to control cells ([Figure 1---figure supplement 3A--B'](#fig1s3){ref-type="fig"}; 30/33 border cells expressed Slbo, n = 6 egg chambers). Proper specification through JAK/STAT signaling restricts the number of follicle cells that become migrating border cells ([@bib81]; [@bib84]). When NiPp1 expression was driven by *c306*-GAL4, the total number of cells in the cluster (border cells and polar cells) was slightly increased to a mean of seven NiPp1 cells compared to six control cells per cluster ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}; n = 27 egg chambers for each genotype). This modest increase in cells per cluster is far fewer than what is observed upon ectopic activation of JAK/STAT ([@bib81]; [@bib84]), suggesting that NiPp1 does not greatly impact the specification or recruitment of border cells. Thus, NiPp1 prevents properly specified border cells from staying together and completing migration.

Live NiPp1 border cell clusters fall apart and move slowly {#s2-2}
----------------------------------------------------------

To determine where and when NiPp1-expressing border cells stopped migrating and dissociated from the cluster, we examined border cell clusters using live time-lapse imaging ([@bib64]; [@bib15]). Both control and NiPp1 border cells delaminated from the surrounding epithelium and began their migration as a group ([Figure 1K--L''](#fig1){ref-type="fig"}; [Videos 1](#video1){ref-type="video"}, [2](#video2){ref-type="video"}, [3](#video3){ref-type="video"}, [4](#video4){ref-type="video"}). NiPp1 border cells separated into multiple sub-clusters or single cells at various points during migration, particularly after moving between the nurse cells ([Videos 2](#video2){ref-type="video"}, [3](#video3){ref-type="video"}, [4](#video4){ref-type="video"}). NiPp1 border cells typically migrated as small groups but also could arrange themselves into co-linear chains ([Video 3](#video3){ref-type="video"}). A few NiPp1 border cells reached the oocyte, although considerably later than control border cells. Indeed, NiPp1-expressing border cells migrated more slowly overall compared to control border cell clusters (\~0.35 µm/min NiPp1 versus \~0.65 µm/min control; [Figure 1M](#fig1){ref-type="fig"}). Individual NiPp1 border cells also moved at variable speeds, with lagging border cells sometimes pushing ahead of the nominal leading cell ([Video 2](#video2){ref-type="video"}). Labeling with a cortical cell membrane marker, PLCδ-PH-EGFP (*slbo*-GAL4 \>UAS-PLCδ-PH-EGFP), allowed us to determine that some NiPp1 border cells completely disrupted their cell-cell contacts, whereas other border cells remained in contact ([Video 5](#video5){ref-type="video"}). Finally, single border cells that broke off from the cluster were frequently left behind and stopped moving forward, appearing to get 'stuck' between nurse cells ([Videos 2](#video2){ref-type="video"}, [3](#video3){ref-type="video"}, [4](#video4){ref-type="video"}). Taken together, these data show that NiPp1 disrupts the ability of border cells to maintain a collective mode of migration, and leads to border cells now moving as single cells or small groups with slower speed that typically fail to reach the oocyte.

###### Control (*c306*-GAL4/+; *UAS*-mCherry-Jupiter/+) egg chamber showing normal border cell migration.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### NiPp1 overexpressing (*c306*-GAL4/+; *UAS*-mCherry-Jupiter/+; *UAS*-NiPp1/+) egg chamber showing the migration defect and splitting phenotype.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### Representative time-lapse video of a stage 9 NiPp1 overexpressing (*c306*-GAL4,tsGAL80/+; *UAS*-mCherry-Jupiter/+; *UAS*-NiPp1/+) egg chamber with DIC channel.

Frames were acquired every 2 min with a 20x objective. Time is in hr:min. Anterior is to the left.

###### Representative time-lapse video of a stage 9 NiPp1 overexpressing (*c306*-GAL4,tsGAL80/+; *UAS*- mCherry-Jupiter /+;*UAS*-NiPp1/+) egg chamber with DIC channel.

Frames were acquired every 2 min with a 20x objective. Time is in hr:min. Anterior is to the left.

###### NiPp1 overexpressing (*slbo-*GAL4/+; UAS- PLCδ-PH-EGFP/UAS-NiPp1) egg chamber showing the loss of a membrane attachment between one border cell and the rest of the border cell cluster.

Anterior is to the left.

NiPp1 inhibits the function of Pp1 catalytic subunits in border cells {#s2-3}
---------------------------------------------------------------------

NiPp1 is a specific inhibitor of Pp1c activity in vitro as well as in vivo ([@bib96]; [@bib61]; [@bib89]). *Drosophila* has four Pp1c subunit genes ([@bib18]; [@bib17]), whereas humans have three genes ([@bib41]). Pp1α−96A, Flapwing (Flw), and Pp1-87B transcripts are each expressed at moderate-to-high levels in the adult ovary, whereas Pp1-13C RNA is mainly detected in adult males (<http://flybase.org/>) ([@bib29]). We examined the localization of Pp1α−96A using a genomic fosmid transgene in which the open reading frame of Pp1α−96A is driven by its endogenous genomic regulatory regions and C-terminally tagged with GFP ('Pp1α−96A-GFP') ([@bib74]). Pp1α−96A-GFP was detected in the cytoplasm, with higher levels at the cortical membranes of border cells, follicle cells, the oocyte, and nurse cells ([Figure 2A--C](#fig2){ref-type="fig"}). Endogenous Flw, as visualized using a functional in-frame YFP protein trap ([@bib98]) ('Flw-YFP'), was also expressed ubiquitously during the stages in which border cells migrate ([Figure 2D--F](#fig2){ref-type="fig"}). Specifically, Flw-YFP was enriched at the cell cortex and cytoplasm of all cells, including border cells. Due to a lack of specific reagents, we were unable to determine whether Pp1-87B or Pp1-13C proteins are present in border cells. Therefore, at least two Pp1c subunit proteins are expressed in border cells throughout their migration.

![Pp1c expression in border cells and specificity of NiPp1 inhibition of Pp1c activity.\
(**A--F**) Stage 9 and 10 egg chambers showing the endogenous patterns of Pp1c subunits (green) in border cells (arrowheads), follicle cells, and the germline nurse cells and oocyte. DAPI (blue) labels nuclei. Insets, zoomed-in detail of border cells from the same egg chambers. (**A--C**) Pp1α−96A (green) expression, visualized by a GFP-tagged fly-TransgeneOme (fTRG) line. (**D--F**) Flw expression (green), visualized by a YFP-protein trap in the endogenous *flw* genetic locus. (**G, H**) Overexpression of *Pp1c* genes rescues the migration (**G**) and cluster cohesion (**H**) defects of NiPp1-expressing border cells. (**G**) Quantification of the migration distance at stage 10 for border cells in NiPp1-expressing egg chambers versus rescue by overexpression of the indicated *Pp1c* genes, shown as complete (green) and incomplete (red) border cell migration (see [Figure 1I](#fig1){ref-type="fig"} for egg chamber schematic). (**H**) Quantification of cluster cohesion at stage 10, shown as the percentage of border cells found as a single unit (one part) or split into multiple parts (two parts, three parts,\>3 parts) in NiPp1-expressing egg chambers versus rescue by overexpression of the indicated *Pp1c* genes. (**G, H**) Error bars represent SEM in three experiments, each trial assayed n ≥ 44 egg chambers (total n ≥ 148 per genotype). \*p\<0.05, \*\*p\<0.01; \*\*\*p\<0.001; \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig2){#fig2}

We next determined whether NiPp1 specifically inhibited Pp1c activity in border cells. Overexpression of each of the four *Drosophila* Pp1c subunits individually did not impair border cell migration ([Figure 2---figure supplement 1A--D](#fig2s1){ref-type="fig"}). When co-expressed with NiPp1, two of the catalytic subunits, Pp1α−96A and Pp1-87B, strongly suppressed the migration defects caused by NiPp1, with 90% (NiPp1 + Pp1α−96A) and 75% (NiPp1 + Pp1-87B) of border cells now reaching the oocyte compared to 40% with NiPp1 alone (NiPp1 + RFP; [Figure 2G](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1F--H](#fig2s1){ref-type="fig"}). Co-expression of Pp1α−96A and Pp1-87B partially suppressed the NiPp1-induced cluster fragmentation, leading to 55% (NiPp1 + Pp1α−96A) and 65% (NiPp1 + Pp1-87B) of border cell clusters now found intact compared to \~10% with NiPP1 alone (NiPp1 + RFP; [Figure 2H](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1F--H](#fig2s1){ref-type="fig"}). Flw and Pp1-13C only mildly suppressed the NiPp1-induced cluster splitting and migration defects ([Figure 2G,H](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1I,J](#fig2s1){ref-type="fig"}). The observed phenotypic suppressions were likely due to titration of NiPp1 inhibitory activity by excess Pp1c protein, in agreement with previous studies in *Drosophila* ([@bib4]; [@bib61]). Partial suppression could be due to levels of overexpressed Pp1c or effectiveness of the respective Pp1c to titrate NiPp1 in border cells. Co-expression of a human Pp1c homolog ('hPPP1CC') fully suppressed the NiPp1-induced phenotypes and did not disrupt migration when expressed on its own ([Figure 2G,H](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1E,K](#fig2s1){ref-type="fig"}). hPPP1CC has high homology to Pp1-87B (93% identical, 96% similar), Pp1α−96A (89% identical, 94% similar), and Pp1-13C (91% identical, 95% similar), with lower homology to Flw (84% identical, 91% similar), although further analysis through the DIOPT *Drosophila*RNAi Screening Center Integrative Ortholog Prediction Tool) database suggests higher homology to Pp1-87B and Pp1α−96A (<http://flybase.org/>) ([@bib32]). The suppression by multiple Pp1 proteins and full suppression by hPPP1CC suggests that Pp1 catalytic subunit genes have overlapping functions in border cells.

To better understand how NiPp1 inhibits Pp1 activity in border cells, we next analyzed the subcellular localization of Flw-YFP and Pp1α−96A-GFP when NiPp1 was co-expressed. Expression of HA-tagged NiPp1 alone was itself predominantly nuclear, with low expression in the cytoplasm ([Figure 2---figure supplement 2A--A''](#fig2s2){ref-type="fig"}). Pp1α −96A-GFP and Flw-YFP normally localize to the cortical membrane and cytoplasm of border cells ([Figure 2A--F](#fig2){ref-type="fig"}). Upon co-expression with NiPp1, however, Flw-YFP and Pp1α −96A-GFP were now primarily localized to border cell nuclei along with NiPp1 (HA-tagged NiPp1; [Figure 2---figure supplement 2B--C"](#fig2s2){ref-type="fig"}). These results suggest that ectopic NiPp1, in addition to directly inhibiting Pp1c activity also sequesters PP1 catalytic subunits in the nucleus ([@bib96]; [@bib61]; [@bib88]).

Pp1c genes are required for border cell cluster migration and cohesion {#s2-4}
----------------------------------------------------------------------

To determine whether Pp1 catalytic activity itself is required for border cell migration, we next downregulated the *Pp1c* genes by driving the respective UAS-RNAi lines with *c306*-GAL4 ([Figure 3A--D](#fig3){ref-type="fig"}). RNAi lines that target 3 of the four catalytic subunits (*Pp1α−96A*, *Pp1-87B*, and *Pp1-13C*) strongly disrupted border cell migration ([Figure 3B--E](#fig3){ref-type="fig"}). The majority of *Pp1c* RNAi border cells either did not migrate ('no migration') or stopped along the migration pathway ('incomplete migration'; [Figure 3E](#fig3){ref-type="fig"}). *Pp1α−96A*-RNAi in particular, caused a significant fraction of border cells to fail to migrate at all, likely due to a failure to delaminate from the epithelium (\~15%; [Figure 3E](#fig3){ref-type="fig"}). Knockdown of *Pp1c* genes also caused ≥50% of border cell clusters to dissociate into multiple sub-clusters and single cells ([Figure 3B--D,F](#fig3){ref-type="fig"}). Using live time-lapse imaging, we confirmed that decreased levels of Pp1α−96A, Pp1-87B, and Pp1-13C by RNAi altered border cell migration and caused cells to split from the main cluster ([Figure 3G](#fig3){ref-type="fig"}; [Videos 6](#video6){ref-type="video"}, [7](#video7){ref-type="video"}, [8](#video8){ref-type="video"}, [9](#video9){ref-type="video"} and [10](#video10){ref-type="video"}). Some *Pp1α−96A*-RNAi border cells did not delaminate from the epithelium during the course of imaging ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}; [Video 8](#video8){ref-type="video"}). Multiple *flw* RNAi lines (see Materials and methods) did not impair migration or cluster cohesion when expressed in border cell clusters. However, RNAi does not always fully knock down gene function in cells ([@bib54]). As complete loss of *flw* is homozygous lethal, we generated border cells that were mosaic mutant for the strong loss of function allele *flw^FP41^* ([@bib85]). Mosaic *flw^FP41^* border cell clusters were typically composed of a mixture of wild-type and mutant cells that frequently fell apart, with \~90% splitting into two or more parts ([Figure 3H--I](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1B--B"](#fig3s1){ref-type="fig"}). In egg chambers with *flw* mutant border cells, 40% of border cell sub-clusters did not delaminate or migrate at all ('no migration') whereas 20% partially migrated but did not reach the oocyte ([Figure 3H--H",J](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1B--B"](#fig3s1){ref-type="fig"}). NiPp1 expression results in more severe phenotypes than RNAi knockdown, or loss, of individual *Pp1c* genes, at least with respect to migration and cluster cohesion, suggesting that Pp1c subunits have both distinct and overlapping functions. In particular, Pp1α−96A and Flw appear to function in border cell delamination, whereas all four subunits likely promote migration and cluster cohesion.

![Pp1c genes are required for normal border cell migration and cluster cohesion.\
(**A--F**) Knockdown of *Pp1c* genes by RNAi disrupts border cell cluster migration and cohesion. (**A--D**) Stage 10 egg chambers expressing RNAi against the indicated genes were stained for SN (red) to label border cells (arrowheads), phalloidin to label F-actin (green) and DAPI to label nuclei (blue). (**E**) Quantification of border cell cluster migration for matched control and RNAi knockdown of the indicated *Pp1c* genes, shown as the percentage of egg chambers with complete (green), partial (blue), or no (red) border cell migration. (**F**) Quantification of cluster cohesion, shown as the percentage of border cells found as a single unit (one part) or split into multiple parts (2--3 parts or \>3 parts) in control versus *Pp1c* RNAi egg chambers. (**E, F**) Error bars represent SEM in three experiments, each trial assayed n ≥ 58 (total n ≥ 229 per genotype). (**G**) Measurement of border cell migration speed in the indicated genotypes from individual videos of *Pp1c* RNAi border cells; n = 14 videos for control, n = 11 videos for *Pp1-87B-RNAi* (27 split parts were tracked), n = 12 videos for *Pp1-13C-RNAi* (17 split parts were tracked), n = 16 videos for *Pp1α-96A-RNAi* (38 split parts were tracked), box-and-whiskers plot (see [Figure 1](#fig1){ref-type="fig"} legend for details of plot). (**E--G**) \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. (**H--J**) *flw* mutant border cells split from the cluster and often fail to migrate. (**H--H''**) Representative image of a stage 10 egg chamber with *flw^FP41^* mutant clones, marked by the loss of nuclear mRFP (dotted outline in H, **H'**) and stained for SN (green in H'\') to mark border cells (arrowheads) and DAPI (blue in H) to mark nuclei. (**I, J**) Quantification of *flw^FP41^* mutant cluster cohesion (**I**) and migration (**J**) at stage 10; n = 20 egg chambers with *flw^FP41^* clones were examined. (**I**) Quantification of cluster cohesion at stage 10, shown as the percentage of *flw^FP41^* mosaic border cells found as a single unit (one part) or split into multiple parts (2, 3, or four parts). (**J**) Quantification of the migration distance at stage 10 for *flw^FP41^* mosaic mutant border cells, shown as complete (green), partial (blue), or incomplete (red) border cell migration. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig3){#fig3}

###### Control (*c306*-GAL4,tsGAL80/+; UAS- PLCδ-PH-EGFP/+) egg chamber showing normal border cell migration.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### Representative time-lapse video of a stage 9 *Pp1α−96A* RNAi (*c306*-GAL4,tsGAL80/+; *v27673*/+; PLCδ-PH-EGFP /+) egg chamber.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### Another representative time-lapse video of a stage 9 *Pp1α−96A* RNAi (*c306*-GAL4,tsGAL80/+; *v27673*/+;UAS-PLCδ-PH-EGFP/+) egg chamber.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### Representative time-lapse video of a stage 9 *Pp1-13C* RNAi (*c306*-GAL4,tsGAL80/+;*v*29058/+;UAS-PLCδ-PH-EGFP/+) egg chamber.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

###### Representative time-lapse video of a stage 9 *Pp1-87B* RNAi (*c306*-GAL4,tsGAL80/+; *v35024*/+;UAS-PLCδ-PH-EGFP/+) egg chamber.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

Pp1 promotes cadherin-catenin complex levels and adhesion of border cells {#s2-5}
-------------------------------------------------------------------------

One of the strongest effects of decreased Pp1c activity was the dissociation of border cells from the cluster. In many cell collectives, cadherins critically mediate the attachment of individual cells to each other during migration, although other cell-cell adhesion proteins can also contribute ([@bib25]; [@bib13]). The cadherin-catenin complex members E-Cadherin (*Drosophila* Shotgun; Shg), β-Catenin (*Drosophila* Armadillo; Arm) and α-Catenin are all required for border cell migration ([@bib8]; [@bib57]; [@bib75]; [@bib16]). E-Cadherin, in particular, is required for traction of border cells upon the nurse cell substrate, for producing overall front-rear polarity within the cluster, and for attachment of border cells to the central polar cells ([@bib8]; [@bib57]). Complete loss of cadherin-catenin complex members in border cells prevents any movement between nurse cells ([@bib57]; [@bib75]; [@bib16]). This has precluded a definitive analysis of whether all, or some, complex members promote adherence of border cells to the polar cells and/or to other border cells.

To determine whether adhesion of border cells to the cluster requires a functional cadherin-catenin complex, we used *c306-*GAL4 to drive RNAi for each gene in all cells of the cluster ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Multiple non-overlapping RNAi lines for *E-Cadherin*, *β-Catenin*, and *α-Catenin* each reduced the respective endogenous protein levels and disrupted border cell migration, in agreement with previous results that used mutant alleles ([Figure 4A--E,G,I](#fig4){ref-type="fig"}; [Figure 4---figure supplement 1A--H'](#fig4s1){ref-type="fig"}; [Video 11](#video11){ref-type="video"}; [@bib57]; [@bib75]; [@bib60]). Importantly, RNAi knockdown for each of the cadherin-catenin complex genes, driven by *c306*-GAL4, resulted in significant fragmentation of the border cell cluster compared to controls. *E-Cadherin* (40--50%) and *β-Catenin* (55--80%) RNAi lines exhibiting stronger, while *α-Catenin* RNAi lines exhibited milder (\~20--30%), cluster fragmentation ([Figure 4A--D,F,H,J](#fig4){ref-type="fig"}; [Video 11](#video11){ref-type="video"}). Dissociated RNAi border cells could localize to the side of the egg chamber ([Figure 4B,D](#fig4){ref-type="fig"}), although others remained on the normal central migration pathway ([Figure 4C,D](#fig4){ref-type="fig"}). While *α-Catenin* RNAi knockdown in polar cells alone (*upd-*GAL4) caused border cell cluster splitting and migration defects, this effect was significantly milder than the effects of *α-Catenin* knockdown in both polar cells and border cells using *c306-*GAL4 (compare [Figure 4I,J](#fig4){ref-type="fig"} to [Figure 4---figure supplement 1I,J](#fig4s1){ref-type="fig"}). These results indicate that the cadherin-catenin complex keeps border cells attached to each other and to the polar cells, which in turn maintains a cohesive cluster.

![The cadherin-catenin complex is required for the collective cohesion of the migrating border cell cluster and is regulated by Pp1.\
(**A--J**) Knocking down *E-Cad*, *β-Cat* or *α-Cat* by RNAi disrupts border cell cluster migration and cohesion. Images of stage 10 egg chambers stained for phalloidin to label F-actin (red) and DAPI to label nuclei (blue). Border cells (arrowheads) express the membrane marker PLCδ-PH-EGFP (green). (**E--J**) Quantification of border cell migration (**E, G, I**) and cluster cohesion (**F, H, J**) in stage 10 control and *E-Cad-RNAi* (**E, F**), *β-Cat-RNAi* (**G, H**) *and α-Cat-RNAi* (**I, J**) egg chambers. The controls for *E-Cad* and *β-Cat-RNAi* are identical, but shown on separate graphs (**E--H**) for clarity; a separate matched control is shown for *α-Cat* RNAi (**I, J**). Error bars represent SEM in three experiments, each trial assayed n ≥ 27 egg chambers (total n ≥ 93 for *each genotype*). \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001; \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. (**E, G, I**) Quantification of border cell migration, shown as the percentage of egg chambers with complete (green), partial (blue), or no (red), border cell migration. (**F, H, J**) Quantification of cluster cohesion, shown as the percentage of border cells found as a single unit (one part) or split into multiple parts (2--3 parts or \>3 parts) in control versus RNAi egg chambers. (**K--N''**) Representative images showing the E-Cad (white in K, L; green in K'\', **L"**) and β-cat (white in M, N; green in M'\', **N"**) protein expression pattern in control and NiPp1 overexpressing (OE) border cells. Border cells were co-stained for DAPI to mark nuclei (white in K', L', M', N'; blue in K'\', **L", M", N"**). Images were generated from merged *z*-sections. The enriched levels of E-Cad (**K, L**) and β-cat (**M, N**) between border cells (border cell-border cell contacts) are marked by yellow and magenta arrows, respectively. The central polar cells are indicated by red arrowheads (**K', L', M', N'**). (**O, P**) Quantification of relative E-Cad (**O**) and β-Cat (**P**) protein intensity levels in control and NiPp1 overexpressing border cell clusters shown as box-and-whiskers plots (see [Figure 1](#fig1){ref-type="fig"} legend for details of plot). For E-Cad, 39 border cell-border cell contacts from eight matched control clusters and 24 border cell-border cell contacts from 16 NiPp1 clusters were measured. For β-Cat, 33 border cell-border cell contacts from seven matched control clusters and 23 border cell-border cell contacts from 15 NiPp1 clusters were measured. \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig4){#fig4}

###### Representative time-lapse video of a stage 9 *α-Cat* RNAi (*c306*-GAL4,tsGAL80/+; *v107298/+;* UAS-PLCδ-PH-EGFP/+) egg chamber.

Frames were acquired every 3 min with a 20x objective. Anterior is to the left.

We next wanted to determine whether Pp1 regulated these adhesion proteins in border cells. We analyzed the levels and localization of E-Cadherin and β-Catenin at cell-cell contacts in NiPp1-expressing border cell clusters that were still intact or loosely connected ([Figure 4K--P](#fig4){ref-type="fig"}). In wild-type clusters, E-Cadherin and β-Catenin are highly enriched at cell contacts between border cells (BC-BC) and between border cells and polar cells (BC-PC; [Figure 4K--K",M--M"](#fig4){ref-type="fig"}). NiPp1-expressing border cell clusters exhibited reduced levels of E-Cadherin and β-Catenin at most BC-BC contacts ([Figure 4L--L",N--N"](#fig4){ref-type="fig"}). Pp1-inhibited polar cells generally retained E-Cadherin and β-Catenin, which was higher compared to border cells ([Figure 4L--L",N--N"](#fig4){ref-type="fig"}). We quantified the relative levels of E-Cadherin ([Figure 4O](#fig4){ref-type="fig"}) and β-Catenin ([Figure 4P](#fig4){ref-type="fig"}) at BC-BC contacts in control versus NiPp1 clusters, normalized to the levels of those proteins at nurse cell-nurse cell junctions. Both E-Cadherin and β-Catenin were reduced by almost half compared to matched controls. These data together suggest that Pp1 activity regulates cadherin-catenin proteins at cell-cell contacts, which contributes to adhesion of border cells within the cluster.

Pp1 activity promotes protrusion dynamics but is dispensable for directional migration {#s2-6}
--------------------------------------------------------------------------------------

Border cells with impaired Pp1 activity migrated significantly slower than control clusters ([Figures 1M](#fig1){ref-type="fig"} and [3G](#fig3){ref-type="fig"}), suggesting that border cell motility was altered. Migrating cells form actin-rich protrusions at the front, or leading edge, which help anchor cells to the migratory substrate and provide traction for forward movement ([@bib71]; [@bib9]). In collectives, protrusive leader cells also help sense the environment to facilitate directional migration ([@bib46]). Border cells typically form one or two major protrusions at the cluster front ([@bib64]; [@bib63]; [@bib92]; [Figure 5A--A"",C](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}; [Video 6](#video6){ref-type="video"}). Pp1-inhibited border cells (Pp1c RNAi) still extended forward-directed protrusions ([Figure 5A--C](#fig5){ref-type="fig"}; [Videos 7](#video7){ref-type="video"}, [8](#video8){ref-type="video"}, [9](#video9){ref-type="video"} and [10](#video10){ref-type="video"}). Additionally, the numbers, lifetimes, lengths and areas of side- and back-directed protrusions were not generally increased in Pp1-inhibited border cell clusters compared to control ([Figure 5C--F](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1B,C](#fig5s1){ref-type="fig"}). However, the number of protrusions produced at the front of the cluster was reduced in Pp1 RNAi border cells (range of 0.5--0.85 mean protrusions per frame, all genotypes) compared to control (1.0 mean protrusions per frame; [Figure 5C](#fig5){ref-type="fig"}). Additionally, the lifetimes of Pp1 RNAi forward-directed protrusions were reduced ([Figure 5D](#fig5){ref-type="fig"}). Control protrusions at the cluster front had a lifetime of \~18 min, whereas Pp1-inhibited front protrusions persisted for 5--10 min. These short-lived Pp1 RNAi protrusions were also reduced in length, from a third to half the size of control front-directed protrusions ([Figure 5E](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Further, Pp1-inhibited front protrusions were smaller, with a mean area of \~10--20 µm^2^ compared to the control mean of \~40 µm^2^ ([Figure 5F](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Thus, Pp1 activity promotes normal protrusion dynamics, including the number, lifetime and size of front-directed protrusions.

![Pp1c is required for normal border cell protrusion dynamics.\
(**A--B""**) Frames from a matched control ([Video 6](#video6){ref-type="video"}; **A--A""**) and a *Pp1α-96A-RNAi* ([Video 8](#video8){ref-type="video"}; **B--B""**) showing the migrating border cell cluster expressing the membrane marker PLCδ-PH-EGFP. Time in min. Arrows indicate protrusions, arrowheads indicate cluster 'parts'. (**C--F**) Quantification of the number of protrusions per frame (**C**), average protrusion lifetime (**D**), average protrusion length (**E**), and average protrusion area (**F**) from videos of the indicated genotypes. Protrusions were defined as in [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"} and in the Materials and methods. For control, protrusions were measured in 14 videos (n = 51 front-directed protrusions, n = 15 side-directed protrusions, n = 2 back-directed protrusions); for *Pp1α-96A-RNAi*, protrusions were measured in n = 16 videos (n = 59 front protrusions, n = 19 side protrusions, n = 9 for back protrusions), for *Pp1-87B-RNAi*, protrusions were measured in 13 videos (n = 67 for front protrusions, n = 10 for side protrusions, n = 3 for back protrusions); for *Pp1-13C-RNAi*, protrusions were measured in 12 videos (n = 61 front protrusions, n = 9 side protrusions, n = 1 back protrusion). Data are presented as box-and-whiskers plots (see [Figure 1](#fig1){ref-type="fig"} legend for details of plot). \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig5){#fig5}

The majority of NiPp1 and Pp1c RNAi border cells followed the normal migratory pathway down the center of the egg chamber between nurse cells, even when cells broke off from the main cluster ([Figure 1H,L--L"](#fig1){ref-type="fig"} and [3B--D](#fig3){ref-type="fig"}; [Videos 2](#video2){ref-type="video"}, [3](#video3){ref-type="video"}, [4](#video4){ref-type="video"}, [5](#video5){ref-type="video"} and [7](#video7){ref-type="video"}, [8](#video8){ref-type="video"}, [9](#video9){ref-type="video"}, [10](#video10){ref-type="video"}). Moreover, in Pp1 RNAi border cells, front-directed protrusions still formed though with altered dynamics. These observations together suggest that Pp1 activity is not required for directional chemotactic migration. To further test this idea, we made use of a Förster Resonance Energy Transfer (FRET) activity reporter for the small GTPase Rac. Normally, high Rac-FRET activity occurs at the cluster front during early migration in response to guidance signals from the oocyte, and correlates with protrusion extension ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}; [@bib92]). Under conditions of PP1-inhibition, the most severely affected clusters fall apart, sometimes on different focal planes, making it difficult to interpret Rac-FRET signal. We therefore measured global Rac-FRET only in those NiPp1-expressing border cell clusters that remained intact. We detected elevated Rac-FRET activity in NiPp1 border cells similar to control, indicating that Rac activity was largely preserved although with slightly elevated levels ([Figure 5---figure supplement 1D,E](#fig5s1){ref-type="fig"}). In sum, these data indicate that Pp1 activity influences protrusion dynamics and cell motility, but does not appear to be critical for directional orientation of the cluster to the oocyte.

Pp1 promotes border cell shape through collectively polarized F-actin and Myo-II {#s2-7}
--------------------------------------------------------------------------------

Migrating cells, including cell collectives, change shape to facilitate their movement through complex tissue environments ([@bib86]). Some cells maintain a single morphology, such as an elongated mesenchymal or rounded amoeboid shape, throughout migration, whereas other cells interconvert from one shape to another as they migrate. The border cell cluster overall is rounded, although individual border cells within the group appear slightly elongated ([Figure 6A,A'](#fig6){ref-type="fig"}; [Videos 1](#video1){ref-type="video"} and [6](#video6){ref-type="video"}; [@bib3]). However, NiPp1 border cells, whether present in small groups or as single cells, were visibly rounder than control border cells ([Figure 1H,L--L"](#fig1){ref-type="fig"}; [Videos 1](#video1){ref-type="video"}--[4](#video4){ref-type="video"}). We observed similar cell rounding when the *Pp1c* genes were knocked down by RNAi, although some border cells appeared more noticeably round than others ([Figures 3B--D](#fig3){ref-type="fig"} and [5B--B""](#fig5){ref-type="fig"}; [Videos 7](#video7){ref-type="video"}--[10](#video10){ref-type="video"}). To quantify these altered cell shapes, we expressed the membrane marker PLCδ-PH-EGFP to visualize individual cells within the cluster and measured 'circularity', which indicates how well a shape approaches that of a perfect circle (1.0; [Figure 6A--C](#fig6){ref-type="fig"}). Control border cells overall were slightly elongated with a mean of \~0.7, although the circularity of individual cells varied substantially (range of \~0.4 to 0.95), suggesting that border cells undergo dynamic shape changes during migration ([Figure 6C](#fig6){ref-type="fig"}). In contrast, NiPp1 border cells were rounder, with a mean of \~0.9, and exhibited less variation than control (range of \~0.7 to 1.0; [Figure 6C](#fig6){ref-type="fig"}).

![Pp1 activity promotes normal border cell shape and distribution of actomyosin in the border cell cluster.\
(**A--C**) Pp1 is required for border cell shape. (**A--B'**) Examples of control (**A, A'**) and NiPp1-expressing border cells (**B, B'**). Cell shape was visualized using the membrane marker PLCδ-PH-EGFP driven by *slbo-*GAL4 (green). Cells were outlined (**A, B**) and measured for circularity (**C**). (**C**) Control border cells are more elongated compared to NiPp1-expressing border cells (closer to 1.0, a perfect circle). Quantification of circularity, showing all data points and the mean; 51 control border cells and 57 NiPp1-expressing border cells were measured. \*\*\*\*p\<0.0001, unpaired two-tailed *t* test. (**D--G**) Pp1 restricts high levels of F-actin to the border cell cluster periphery. Egg chambers were stained for phalloidin to detect F-actin (green in D, E; white in D', **E'**) and DAPI to visualize nuclei (white in D, **E**). (**D, D'**) Control wild-type border cells (*w^1118^*) have higher F-actin at the cluster perimeter (magenta arrows) and low levels at cell-cell contacts inside the cluster (yellow arrows). (**E, E'**) NiPp1 overexpression increases F-actin inside the cluster at cell contacts between border cells and at cell contacts between polar cells and border cells (yellow arrows). F-actin is relatively high on the outer surfaces of border cells (magenta arrows). (**F, G**) Plot profiles of normalized F-actin (orange) and DAPI (blue) fluorescence pixel intensity (AU, arbitrary units) measured along the lines shown in (**D**) and (**E**); similar results were obtained from additional border cell clusters (n = 11 for control and n = 8 for *slbo* \>NiPp1). (**H--I'''''**) Pp1 restricts Myo-II, as visualized by Sqh-GFP, to the cluster periphery in live border cells. Stills from confocal videos of Sqh-GFP in mid-staged border cells over the course of 20 min. Enriched Sqh-GFP is marked by arrowheads. Imaging gain and other acquisition parameters were the same, except that the range of *z*-stacks vary slightly. Similar patterns were observed for control in n = 8 movies and n = 10 for NiPp1 overexpression. (**H--H""'**) Control border cells ([Video 16](#video16){ref-type="video"}). (**I--I""'**) NiPp1 overexpression ([Video 17](#video17){ref-type="video"}) changes the dynamics of Sqh-GFP, with more Sqh-GFP located in individual border cells and at cell contacts between border cells. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig6){#fig6}

The rounder cell shapes suggested that Pp1 inhibition alters the cortical cytoskeleton of the border cells. Wild-type border cells exhibit a marked enrichment of F-actin at the cluster periphery, whereas lower levels are detected inside the cluster at contacts between border cells ([Figure 6D,D',F](#fig6){ref-type="fig"}; [Video 12](#video12){ref-type="video"}; [@bib43]; [@bib94]). Upon Pp1 inhibition, F-actin now accumulated around each individual border cell, especially at BC-BC membrane contacts, rather than just being enriched at outer cluster surfaces ([Figure 6E,E',G](#fig6){ref-type="fig"}; [Video 13](#video13){ref-type="video"}). Similarly, Myo-II as visualized by GFP-tagged Spaghetti Squash (Sqh-GFP), the *Drosophila* homolog of the myosin regulatory light chain (MRLC), is highly dynamic and normally concentrates in enriched foci at the outer periphery of live border cell clusters both during early ([Figure 6---figure supplement 1A--A""'](#fig6s1){ref-type="fig"}; [Video 14](#video14){ref-type="video"}) and later stages of migration ([Figure 6H--H""'](#fig6){ref-type="fig"}; [Video 16](#video16){ref-type="video"}; [@bib3]; [@bib14]; [@bib44]). In NiPp1 border cells, however, Sqh-GFP was now present at cortical cell membranes in dynamic foci surrounding each border cell (or sub-cluster) rather than at the entire cluster periphery, both during early migration ([Figure 6---figure supplement 1B--B""'](#fig6s1){ref-type="fig"}; [Video 15](#video15){ref-type="video"}) and at mid-migration stages ([Figure 6I--I""'](#fig6){ref-type="fig"}; [Video 17](#video17){ref-type="video"}). Thus, inhibition of Pp1 converts collectively polarized F-actin and Myo-II to that characteristic of single migrating cells. As a result, individual border cells now have enriched and dynamic actomyosin localization consistent with elevated cortical contractility in single cells rather than at the collective level.

###### Control (LifeAct-GFP/+) egg chamber showing the dynamics of F-actin with LifeAct-GFP, Frames were acquired every 2 min with a 40x water immersion objective.

We observed similar dynamics in three videos. Anterior is to the left.

###### NiPp1 overexpressing (*slbo*-Gal4/+; UAS-NiPp1/LifeAct-GFP) egg chamber showing F-actin dynamics with LifeAct-GFP.

Frames were acquired every 2 min with a 40x water immersion objective. We observed similar dynamics in three videos. Anterior is to the left.

###### Control (*c306*-GAL4, tsGAL80/+; Sqh-GFP/+) egg chamber showing normal Sqh-GFP dynamics in early migration.

Frames were acquired every 1 min with a 40x water immersion objective, only a single focal plane is shown, with a 3D projection of the entire z-stack at the beginning and the end of the video. Similar patterns were observed in three videos. Anterior is to the left.

###### Representative NiPp1 overexpressing (*c306-*GAL4, tsGAL80/+; UAS-NiPp1/Sqh-GFP) egg Chamber showing the Sqh-GFP dynamics in early migration.

Frames were acquired every 1 min with a 40x water immersion objective, only a single focal plane is shown, with a 3D projection of the entire z-stack at the beginning and the end of the video. Similar patterns were observed in four videos. Anterior is to the left.

###### Control (Sqh-GFP/+) egg chamber showing normal Sqh-GFP dynamics in mid-migration.

Frames were acquired every 1 min with a 40x water immersion objective, only a single focal plane is shown, with a 3D projection of the entire z-stack at the beginning and the end of the video. Similar patterns were observed in five videos. Anterior is to the left.

###### Representative NiPp1 overexpressing (*c306*-GAL4, tsGAL80/+; UAS-NiPp1/Sqh-GFP) egg chamber showing the Sqh-GFP dynamics in mid-migration.

Frames were acquired every 1 min with a 40x water immersion objective, only a single focal plane is shown, with a 3D projection of the entire z-stack at the beginning and the end of the video. Similar patterns were observed in six videos. Anterior is to the left.

Pp1 promotes actomyosin contractility in border cells through myosin phosphatase {#s2-8}
--------------------------------------------------------------------------------

Rok and other kinases phosphorylate the Myo-II regulatory light chain Sqh ([@bib91]). This leads to fully activated Myo-II, which then forms bipolar filaments, binds to F-actin, and promotes cell contractility. Given the altered distribution of Sqh-GFP when Pp1 was inhibited, we next analyzed the levels and distribution of active Myo-II. We used an antibody that recognizes phosphorylated Sqh at the conserved Ser-21 (mammalian MRLC Ser-19; 'p-Sqh') ([@bib44]). Control border cells exhibited p-Sqh signal primarily at the cluster periphery ('BC-NC' contacts; [Figure 7A--A''](#fig7){ref-type="fig"}). This pattern of p-Sqh closely resembles the pattern of Sqh-GFP in live wild-type border cells ([Figure 6H--H""'](#fig6){ref-type="fig"}; [@bib3]; [@bib44]; [@bib100]; [@bib62]). NiPp1 border cells, however, had high levels of p-Sqh distributed throughout the cluster including at internal BC-BC contacts ([Figure 7B--B''](#fig7){ref-type="fig"}), similar to Sqh-GFP in live NiPp1 border cells ([Figure 6I--I""'](#fig6){ref-type="fig"}). We measured the relative ratio of p-Sqh fluorescence intensity at BC-NC contacts versus BC-BC contacts in control and NiPp1 border cell clusters ([Figure 7C](#fig7){ref-type="fig"}). Control border cells had a higher p-Sqh ratio than NiPp1, indicating less p-Sqh signal at BC-BC contacts. These data support the idea that Pp1 inhibition elevates Myo-II activation within single border cells and at BC-BC contacts.

![Pp1, through myosin phosphatase, promotes contractility of the cluster.\
(**A--B''**) Pp1 restricts Myo-II activation to the cluster periphery. Representative images showing p-Sqh localization (white in A, B; red in A'', (**B''**) and membrane GFP (PLCδ-PH-EGFP; green in A', (**A'', B', B''**) in control (**A--A''**) and NiPp1 overexpressing (**B--B''**) border cells; DAPI labels nuclei (blue in A'', (**B''**). There is an increase in p-Sqh levels (arrowheads) at the interface between border cells when NiPp1 is overexpressed. (**C**) Quantification of the mean pixel intensity of p-Sqh as a ratio of BC:NC/BC:BC. BC:NC stands for border cell-nurse cell interfaces, while BC:BC stands for border cell-border cell interfaces. N = 15 for control and n = 11 for NiPp1 overexpression. (**D--H**) Knocking down *Mbs* disrupts border cell migration and cluster cohesion. (**D--F**) Stage 10 control (**D**) and *Mbs* RNAi (**E,F**) egg chambers stained for SN to label border cells (green), phalloidin to label F-actin (red) and DAPI to label nuclei (blue). (**G**) Quantification of border cell cluster migration for matched control and *Mbs-RNAi*, shown as the percentage that did not complete (red), or completed (green) their migration to the oocyte (see [Figure 1I](#fig1){ref-type="fig"} for egg chamber schematic). (**H**) Quantification of cluster cohesion at stage 10, shown as the percentage of border cells found as a single unit (one part) or split into multiple parts (two parts, three parts,\>3 parts) in control versus *Mbs-RNAi* border cells. (**G, H**) Each trial assayed n ≥ 61 egg chambers (total n ≥ 220 per genotype). \*\*p\<0.01; \*\*\*\*p\<0.0001; unpaired two-tailed *t* test. All genotypes are listed in [Table 2](#table2){ref-type="table"}.](elife-52979-fig7){#fig7}

Myo-II undergoes cycles of activation and inactivation via phosphorylation and dephosphorylation, respectively, to generate dynamic cellular contraction in vivo ([@bib91]). We previously showed that waves of dynamic Myo-II maintain the collective morphology of border cells to facilitate movement through the egg chamber ([@bib3]). The myosin phosphatase complex consists of a Pp1c subunit and a specific regulatory subunit, the myosin binding subunit (Mbs; also called myosin phosphatase-targeting subunit \[MYPT\]), which together dephosphorylate Sqh and inactivate Myo-II ([@bib28]). Previously, we found that Mbs was required for border cell cluster delamination from the epithelium and cell shape ([@bib3]; [@bib44]), although cluster cohesion had not been explicitly assessed. We therefore wanted to determine whether myosin phosphatase contributed to the above-described Pp1 functions in cell shape, cluster cohesion and migration. First, we confirmed that Mbs transcript and protein were expressed in border cells throughout migration ([Figure 7---figure supplement 1A--F](#fig7s1){ref-type="fig"}). Mbs protein colocalized with Pp1c subunits near border cell membranes and in the cytoplasm ([Figure 7---figure supplement 1G--J](#fig7s1){ref-type="fig"}). In general, Mbs colocalized more extensively with Flw-YFP than with Pp1α−96A-GFP ([Figure 7---figure supplement 1G--J](#fig7s1){ref-type="fig"}).

Next, we analyzed the functions of Mbs in border cells. Border cells deficient for Mbs (*Mbs-*RNAi) were rounder than control border cells, exhibited incomplete migration (\~30%), and dissociated from the cluster (60%) along the migration pathway ([Figure 7D--H](#fig7){ref-type="fig"}). The phenotypes observed with *Mbs-*RNAi were generally milder than those observed with Pp1-inhibition (either NiPp1 or *Pp1c-*RNAi; compare to [Figures 1I,J](#fig1){ref-type="fig"} and [3E,F](#fig3){ref-type="fig"}). This could be due to incomplete knockdown by *Mbs-*RNAi, although we observed significant decreases in the levels of endogenous Mbs ([Figure 7---figure supplement 1K--L"](#fig7s1){ref-type="fig"}). Alternatively, myosin phosphatase, through a complex of Mbs/Pp1c, could be one of multiple Pp1 complexes required for border cell cluster migration and cohesion (*see* Discussion). Nonetheless, these findings indicate that myosin phosphatase, a specific Pp1 complex, helps promote the normal cell morphology and collective cohesion of border cells, in addition to facilitating the successful migration of the border cells.

RhoA activates Rho-associated kinase (Rok), thus leading to activation of Myo-II ([@bib91]). We and others previously found that expression of constitutively-activated RhoA (*Drosophila* Rho1) causes markedly rounder border cells and alters the distribution of F-actin and Myo-II at cell-cell contacts between border cells ([@bib3]; [@bib14]). We therefore investigated whether Pp1 regulated RhoA activity in migrating border cells. We used a FRET construct that was recently shown to specifically report RhoA activity in ovarian follicle cells ([@bib66]). Inhibition of Pp1 by NiPp1 moderately increased the overall levels of Rho-FRET in intact border cell clusters compared to control border cells ([Figure 7---figure supplement 2A--C](#fig7s2){ref-type="fig"}). These data suggest a general upregulation of the RhoA pathway upon Pp1 inhibition.

Interplay between cadherin-catenin adhesion and actomyosin dynamics {#s2-9}
-------------------------------------------------------------------

During cellular morphogenesis, the cadherin-catenin complex and actomyosin contractility can interact to influence cell-cell junction stability ([@bib50]; [@bib99]; [@bib65]; [@bib68]; [@bib40]). Given the effects of Pp1 inhibition on the cadherin-catenin complex, F-actin, and Myo-II, we asked whether the observed Pp1-dependent phenotypes were secondarily due to decreased adhesion and/or altered actomyosin contractility. Knockdown of *E-cadherin* or *β-catenin* by RNAi decreased the enrichment of F-actin and p-Sqh at the cluster periphery compared to controls ([Figure 6---figure supplement 2A--C', E--G,I--K](#fig6s2){ref-type="fig"}). This is in agreement with a recent study that observed decreased cortical Myo-II in live *E-cadherin-*RNAi border cells ([@bib52]). Despite this decrease in F-actin, migrating live *α-Catenin* RNAi border cells, while slower than control, extended protrusions with normal dynamics ([Figure 5---figure supplement 1F--J](#fig5s1){ref-type="fig"}). Interestingly, F-actin was also no longer enriched at the cluster periphery of *Sqh-*RNAi border cells ([Figure 6---figure supplement 2D,D',H](#fig6s2){ref-type="fig"}). Thus, F-actin enrichment at the cluster periphery requires both cadherin-catenin and Myo-II. Moreover, the cadherin-catenin complex promotes enriched activated Myo-II at the outer cluster.

Next, we asked if Myo-II was required for cadherin-catenin enrichment at border cell-border cell junctions. *Sqh-*RNAi border cells had normal levels of E-cadherin ([Figure 6---figure supplement 3A--B'', E](#fig6s3){ref-type="fig"}) and normal to slightly higher levels of β-catenin ([Figure 6---figure supplement 3C--D'', F](#fig6s3){ref-type="fig"}). Knockdown of *Sqh* did not disrupt distribution of E-cadherin or β-catenin at border cell-border cell contacts ([Figure 6---figure supplement 3A--D''](#fig6s3){ref-type="fig"}). These data suggest that Myo-II is not a major regulator of the cadherin-catenin complex in border cells. The phenotypes observed with RNAi-mediated knockdown of the cadherin-catenin complex and Sqh are in contrast to those observed with Pp1 inhibition (e.g. [Figures 5](#fig5){ref-type="fig"}--[7](#fig7){ref-type="fig"}). These results are consistent with a more direct role for Pp1 activity in controlling collective versus single cell dynamics of actomyosin and cadherin-catenin in border cells.

Discussion {#s3}
==========

To migrate collectively, cells need to coordinate and cooperate at the multicellular level. Individual cells within a group must remain together, maintain optimal cell shapes, organize motility of neighboring cells, and polarize. The mechanisms that globally orchestrate single cell behaviors within migrating cell collectives are still unclear. Here we report that Pp1 activity is a critical regulator of key intra- and intercellular mechanisms that together produce collective border cell migration. Loss of Pp1 activity, through overexpression of NiPp1 or Pp1c RNAi, switches border cells from migrating as a cohesive cluster to moving as single cells or in small groups ([Figure 8A](#fig8){ref-type="fig"}). A critical aspect of this switch is the redistribution of enriched F-actin and Myo-II to cell contacts between individual border cells, rather than at the cluster periphery, and a concomitant loss of adhesion between cells. We identified one key Pp1 phosphatase complex, myosin phosphatase, that controls collective-level myosin contraction ([Figure 8B](#fig8){ref-type="fig"}). Additional phosphatase complexes, through as-yet-unknown regulatory subunits, likely function in border cells to generate collective F-actin organization, maintain cell-cell adhesions, and potentially to restrain overall RhoA activity levels. Our results support a model in which balanced Pp1 activity promotes collective border cell cluster migration, and timely delamination from the epithelium, by coordinating single border cell motility and keeping the cells together ([Figure 8A](#fig8){ref-type="fig"}).

![Model for the Pp1 function in border cell migration.\
(**A**) Schematic of the phenotypes and the localizations of Pp1c, F-actin, p-Sqh, and the cadherin-catenin complex during normal and Pp1-inhibited (NiPp1 expression or *Pp1c-RNAi*) border cell cluster migration. (**B**) Proposed molecular pathways regulated by Pp1, which together promote cohesive collective border cell migration.](elife-52979-fig8){#fig8}

Many collectively migrating cells require a supracellular enrichment of actomyosin at the group perimeter to help organize their movement ([@bib80]; [@bib79]; [@bib31]; [@bib70]). Active Myo-II is required for border cell collective detachment from the epithelium, cluster shape, rotational movement of the cluster, and normal protrusion dynamics ([@bib3]; [@bib14]; [@bib44]; [@bib52]; [@bib26]). We show here that Pp1 organizes collective-level Myo-II-contractility during border cell migration. Inhibition of Pp1 shifts the balance of dynamic activated Myo-II from the cluster-level to individual border cells, resulting in rounded, hyper-contractile border cells that dissociate from the cluster. The myosin-specific Pp1 complex, myosin phosphatase, directly dephosphorylates Sqh and inhibits Myo-II activation ([@bib28]). Depletion of Mbs, the myosin-binding regulatory subunit of myosin phosphatase, causes rounder border cells and fragmentation of the cluster. We previously found that Mbs-deficient border cells have significantly higher levels of phosphorylated Sqh (p-Myo-II) ([@bib44]). Thus, myosin phosphatase inhibits Myo-II activation to promote coordinated collective contractility of border cells. Myosin phosphatase is a downstream target of Rok, which phosphorylates and inhibits the Mbs subunit ([@bib37]). Consistent with loss of myosin phosphatase activity, Pp1-inhibition increases phosphorylated active Sqh in individual border cells within the cluster. Thus, myosin phosphatase, downstream of Rok, promotes elevated active Myo-II (p-Sqh/p-Myo-II) and cortical contraction of the entire collective ([Figure 8B](#fig8){ref-type="fig"}). Interestingly, expression of constitutively activated RhoA also induces cellular hypercontractility, resulting in amoeboid-like round border cells ([@bib3]; [@bib14]; [@bib52]). RhoA activates Rok, which directly phosphorylates and activates the Myo-II regulatory subunit Sqh ([@bib1]; [@bib45]). We observe somewhat elevated RhoA activity in the absence of Pp1 activity. Thus, Pp1 may also restrain the overall levels of RhoA activity in border cells through an unknown Pp1 complex, which would further promote the collective actomyosin contraction of border cells ([Figure 8B](#fig8){ref-type="fig"}).

Myo-II is activated preferentially at the cluster periphery and not between internal border cell contacts. Mbs and at least one catalytic subunit, Flw, localize uniformly in border cells, both on the cluster perimeter and between cells. Such uniform phosphatase distribution would be expected to dephosphorylate and inactivate Myo-II everywhere, yet phosphorylated Sqh is only absent from internal cluster border cell contacts. Rok phosphorylates and inactivates Mbs in addition to directly activating Myo-II ([@bib37]). Our previous results indicate that Rok localizes to the cluster perimeter similar to p-Sqh, but there appeared to be overall less Rok between border cells ([@bib3]). Thus, spatially localized Rok could inhibit myosin phosphatase and activate Myo-II preferentially at the outer edges of the cluster ([Figure 8A](#fig8){ref-type="fig"}). Other mechanisms likely contribute to collective polarization of Myo-II. For example, during border cell detachment from the epithelium the polarity kinase Par-1 phosphorylates and inactivates Mbs at the cluster rear resulting in increased active Myo-II, whereas the Hippo pathway prevents accumulation of phosphorylated Myo-II between border cells ([@bib43]; [@bib44]).

Our data also support a role for Pp1 in controlling F-actin stability, dynamics, and spatial organization. Similar to the pattern of activated Myo-II, cortical F-actin is normally high at the cluster periphery, although low levels are found between border cells ([@bib67]; [@bib43]; [@bib94]). Reduced Pp1 activity causes high levels of F-actin to redistribute from the cluster perimeter to surround entire cell cortices of individual border cells. In migrating cells, networks of F-actin produce forces essential for protrusion extension and retraction dynamics that generate forward movement ([@bib71]; [@bib9]). Further supporting a role for Pp1 in regulating F-actin, Pp1-inhibited border cells extend fewer protrusions with shorter lifetimes, resulting in altered motility patterns. How Pp1 promotes F-actin organization and dynamics is unknown. One possibility comes from the known function for Rok in regulating F-actin through the downstream effector LIM Kinase (LIMK) ([@bib36]). LIMK phosphorylates and inhibits cofilin, an actin severing and depolymerizing factor ([@bib7]). In border cells, cofilin restrains F-actin levels throughout the cluster and increases actin dynamics, resulting in normal cluster morphology and major protrusion formation ([@bib101]). Although cofilin dephosphorylation, and thus activation, is typically mediated by the dual-specificity phosphatase Slingshot ([@bib7]), Pp1-containing complexes have been shown to dephosphorylate cofilin in a variety of cell types ([@bib34]; [@bib2]; [@bib102]; [@bib58]). Additionally, RhoA activates formin proteins such as Diaphanous, which nucleate actin to form long filaments ([@bib38]). There are at least seven formin-related proteins in *Drosophila*, several of which have domains associated with activation by Rho GTPases. However, which formin, if any, promotes border cell migration and F-actin distribution is unknown. Further work will be needed to determine whether any of these potential targets, or other actin regulatory proteins, control collective level F-actin enrichment via Pp1.

A major consequence of decreased Pp1 activity is fragmentation of the border cell cluster into single border cells and small groups. This raises the question of how Pp1 activity maintains cluster cohesion, which is critical for collective cell movement in vivo. Like many cell collectives, high levels of cadherin-catenin complex proteins are detected between all border cells ([@bib57]). The cadherin-catenin complex is required for border cells to adhere to the central polar cells as well as to provide migratory traction of the entire cluster upon the nurse cells ([@bib8]; [@bib57]). We found that Pp1 maintains E-Cadherin and β-Catenin levels between border cells. Indeed, other mutants that disrupt the levels and localization of adhesion proteins in border cells often also disrupt cluster shape and cohesion. For example, loss of JNK signaling causes border cell clusters to dramatically elongate, with downregulation of adhesion resulting in incomplete separation of border cells ([@bib42]; [@bib51]). Raskol, a putative Ras guanine nucleotide activating protein (GAP), maintains E-cadherin at BC-BC contacts and cohesion of the cluster ([@bib69]). However, while loss of *Raskol* causes a significant number of border cells to fully dissociate from the cluster (\~35%) ([@bib69]), similar to what we observe with knockdown of the cadherin-catenin complex, this is less than what we observe upon inhibition of Pp1 activity (\~90%). Thus, while cluster fragmentation caused by Pp1 inhibition is at least partly due to deficient cadherin-catenin adhesion, other targets likely contribute.

Our results indicate that E-Cadherin, β-Catenin, and α-Catenin maintain adhesion of border cells to each other in addition to known roles in keeping border cells attached to the polar cells ([@bib8]). Knockdown of the cadherin-catenin complex members in both border cells and polar cells causes border cells to significantly dissociate from the cluster. The requirement in border cells for cadherin-catenin in cluster cohesion may have been masked in prior studies due to the inability of strong loss-of-function cadherin-catenin mutant border cells to move at all ([@bib8]; [@bib57]; [@bib75]; [@bib16]). While RNAi for E-Cadherin, β-Catenin, and α-Catenin each strongly knock down the respective protein levels, it may be that a small amount of each protein is still present. Such remaining cadherin-catenin proteins may provide just enough traction for border cells to partially migrate upon the nurse cells. We speculate that movement of cadherin-catenin-deficient border cells within the confining tissue would provide mechanical stresses that break the cluster apart at weakened border cell-border cell contacts. Indeed, a mutant α-Catenin protein that lacks part of the C-terminal F-actin-binding domain was shown to partially rescue the migration defects caused by loss of *α-Catenin*; however, these rescued border cell clusters split into several parts along the migration path ([@bib16]). Further supporting this idea, Pp1-inhibited border cells fall apart during their effort to migrate between the nurse cells.

How do Pp1 phosphatase complexes molecularly promote cluster cohesion? Given the effects of Pp1 on E-Cadherin and β-Catenin at internal border cell contacts, and the requirement for cadherin-catenin complex proteins in maintaining cluster integrity, Pp1 could directly regulate cadherin-catenin protein stability and/or adhesive strength. In mammalian and *Drosophila* cells, phosphorylation of a conserved stretch of serine residues in the E-Cadherin C-terminal tail region regulates E-Cadherin protein stability, binding of E-Cadherin to β-Catenin, and cell-cell junction formation and turnover ([@bib83]; [@bib48]; [@bib11]). Serine-phosphorylation of α-Catenin is also required for adhesion between epithelial cells and possibly for efficient border cell migration ([@bib20]). More work will be needed to determine whether a to-be-identified Pp1-containing phosphatase complex directly dephosphorylates E-Cadherin and/or α-Catenin, as the roles for phosphatases in cadherin-catenin junctional stability are still poorly understood.

Alternatively, or in addition, Pp1-dependent restriction of collective actomyosin contraction to the cluster periphery could allow internal cluster cell-cell junctions to be maintained. Pp1-inhibition greatly alters actomyosin distribution, causing individual border cells to contract and round up. The forces transmitted by high cell contractility alone could weaken adherens junctions, causing the border cells to break apart during migration ([Figure 8A](#fig8){ref-type="fig"}). Myosin phosphatase-depleted border cells, which have elevated phosphorylated Sqh ([@bib44]), and thus active Myo-II, are round, highly contractile, and fall off the cluster. In support of this idea, overexpression of a phosphorylation mutant form of Sqh (Sqh^E20E21^), which mimics activated Myo-II, causes border cells to have a similar round shape and separate from the cluster ([@bib52]). Thus, collective-level active actomyosin contraction contributes to keeping border cells adhered to the cluster. Myo-II and cadherin-catenin complexes have dynamic and quite complex interactions that influence stability of cell-cell junctions, and which may depend on cellular context ([@bib50]; [@bib99]). In border cells, the cadherin-catenin complex promotes enrichment of actomyosin to the cluster periphery, whereas Myo-II does not greatly influence cadherin-catenin levels within the cluster (this study) ([@bib52]). However, Pp1 is required for the proper distribution (or stability) of cadherin-catenin at cell contacts between border cells and prevents the enrichment of actomyosin in individual border cells. Moreover, NiPp1 expression disrupts cluster cohesion to a greater extent than knockdown of either myosin phosphatase or cadherin-catenin complex members alone. This suggests that cadherin-catenin stability and optimal collective-wide actomyosin activity both contribute to cluster cohesion through distinct Pp1 phosphatase complexes, although this possibility remains to be formally tested ([Figure 8B](#fig8){ref-type="fig"}).

Our study implicates Pp1 as a major regulator of collective cohesion and migration in border cells. Pp1 catalytic subunits and their regulatory subunits are conserved across eukaryotes ([@bib41]; [@bib90]; [@bib30]; [@bib22]). The roles of specific Pp1 complexes in collective cell migration during development and in cancer have not been well studied. Intriguingly, Mypt1 (Mbs homolog) promotes polarized mesodermal migration during zebrafish gastrulation ([@bib95]). Similar to what we observe in Mbs-depleted border cells, inhibition of zebrafish Mypt1 switched cells from an elongated mesenchymal mode of migration to a hyper-contractile amoeboid mode of migration. Another Pp1 phosphatase complex containing the Phactr4 (phosphatase and actin regulator 4) regulatory subunit promotes the chain-like collective migration of enteric neural crest cells, which colonize the gut and form the enteric nervous system during development ([@bib102]). Phactr4, through Pp1, specifically controls the directed migration and shape of enteric neural crest cells through integrin, Rok, and cofilin. Given the conservation of these and other phosphatase complexes, our study highlights the importance of balanced Pp1 phosphatase activity in the organization and coordination of migrating cell collectives.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                 Designation                                                    Source or reference                                             Identifiers                                                                      Additional\
  (species) or resource                                                                                                                                                                                                                                         information
  --------------------------------------------- -------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------------------------------- --------------------------------
  Genetic reagent (*Drosophila melanogaster*)   *c306-*GAL4 tsGAL80                                            [@bib3]                                                                                                                                          Laboratory of Jocelyn McDonald

  Genetic reagent (*D. melanogaster*)           *slbo*-GAL4                                                    other                                                           FBal0089668                                                                      from D. Montell

  Genetic reagent (*D. melanogaster*)           *upd*-GAL4                                                     other                                                           FBal0047063                                                                      from D. Montell

  Genetic reagent (*D. melanogaster*)           *c306-*GAL4                                                    Bloomington *Drosophila *Stock Center                           BDSC Cat\# 3743; RRID:[BDSC_3743](https://scicrunch.org/resolver/BDSC_3743)      

  Genetic reagent (*D. melanogaster*)           *UAS*-NiPp1.HA                                                 Bloomington *Drosophila *Stock Center                           BDSC Cat\# 23711; RRID:[BDSC_23711](https://scicrunch.org/resolver/BDSC_23711)   

  Genetic reagent (*D. melanogaster*)           *UAS*-Pp1-87B.HA                                               Bloomington *Drosophila *Stock Center                           BDSC Cat\# 24098; RRID:[BDSC_24098](https://scicrunch.org/resolver/BDSC_24098)   

  Genetic reagent (*D. melanogaster*)           *UAS*-Pp1-13C.HA                                               Bloomington *Drosophila *Stock Center                           BDSC Cat\# 23701; RRID:[BDSC_23701](https://scicrunch.org/resolver/BDSC_23701)   

  Genetic reagent (*D. melanogaster*)           *UAS*-Pp1alpha-96A.HA                                          Bloomington *Drosophila *Stock Center                           BDSC Cat\# 23700; RRID:[BDSC_23700](https://scicrunch.org/resolver/BDSC_23700)   

  Genetic reagent (*D. melanogaster*)           *UAS*-hPPP1CC                                                  Bloomington *Drosophila *Stock Center                           BDSC Cat\# 64394; RRID:[BDSC_64394](https://scicrunch.org/resolver/BDSC_64394)   

  Genetic reagent (*D. melanogaster*)           *UAS-mCherry RNAi*                                             Bloomington *Drosophila *Stock Center                           BDSC Cat\# 35785; RRID:[BDSC_35785](https://scicrunch.org/resolver/BDSC_35785)   VALIUM20-mCherry

  Genetic reagent (*D. melanogaster*)           *UAS*-mCD8.ChRFP                                               Bloomington *Drosophila *Stock Center                           BDSC Cat\# 27392; RRID:[BDSC_27392](https://scicrunch.org/resolver/BDSC_27392)   

  Genetic reagent (*D. melanogaster*)           *flw*^FP41^ FRT 19A                                            Bloomington *Drosophila *Stock Center                           BDSC Cat\# 51338; RRID:[BDSC_51338](https://scicrunch.org/resolver/BDSC_51338)   

  Genetic reagent (*D. melanogaster*)           *Ubi-*mRFP.nls, hsFLP, FRT19A                                  Bloomington *Drosophila *Stock Center                           BDSC Cat\# 31418; RRID:[BDSC_31418](https://scicrunch.org/resolver/BDSC_31418)   

  Genetic reagent (*D. melanogaster*)           *UAS-*PLCδ-PH-GFP                                              Bloomington *Drosophila *Stock Center                           BDSC Cat\# 39693; RRID:[BDSC_39693](https://scicrunch.org/resolver/BDSC_39693)   

  Genetic reagent (*D. melanogaster*)           *UAS-Pp1α−96A RNAi*                                            Vienna *Drosophila *Resource Center                             VDRC:27673                                                                       GD-11970

  Genetic reagent (*D. melanogaster*)           *UAS-Pp1-87B RNAi*                                             Vienna *Drosophila *Resource Center                             VDRC:35024                                                                       GD-11720

  Genetic reagent (*D. melanogaster*)           *UAS-Pp1-13C RNAi*                                             Vienna *Drosophila *Resource Center                             VDRC:29057                                                                       GD-14139

  Genetic reagent (*D. melanogaster*)           *UAS-Mbs RNAi*                                                 Vienna *Drosophila *Resource Center                             VDRC:105762                                                                      KK-109231

  Genetic reagent (*D. melanogaster*)           *UAS-E-cad RNAi*                                               Vienna *Drosophila *Resource Center                             VDRC:103962                                                                      KK-103334

  Genetic reagent (*D. melanogaster*)           *UAS-E-cad RNAi*                                               Vienna *Drosophila *Resource Center                             VDRC:27082                                                                       GD-14421

  Genetic reagent (*D. melanogaster*)           *UAS-β-cat RNAi*                                               Vienna *Drosophila *Resource Center                             VDRC:107344                                                                      KK-102545

  Genetic reagent (*D. melanogaster*)           *UAS-β-cat RNAi*                                               Vienna *Drosophila *Resource Center                             BDSC:31305                                                                       TRiP.JF01252

  Genetic reagent (*D. melanogaster*)           *UAS-α-cat RNAi*                                               Vienna *Drosophila *Resource Center                             VDRC:107298                                                                      KK-107916

  Genetic reagent (*D. melanogaster*)           *UAS-α-cat RNAi*                                               Vienna *Drosophila *Resource Center                             VDRC:20123                                                                       GD-8808

  Genetic reagent (*D. melanogaster*)           *fTRG sqh*                                                     Vienna *Drosophila *Resource Center                             VDRC:318484                                                                      fTRG 10075

  Genetic reagent (*D. melanogaster*)           *fTRG Pp1α −96A*                                               Vienna *Drosophila *Resource Center                             VDRC:318084                                                                      fTRG 290

  Genetic reagent (*D. melanogaster*)           flwCPTI002264                                                  Kyoto *Drosophila *Genomics and Genetic Resources               line 115284                                                                      FBti0143758

  Genetic reagent (*D. melanogaster*)           *UAS*-Flw.HA                                                   The Zurich ORFeome Project,FlyORF                               line F001200                                                                     

  Antibody                                      rat monoclonal anti-E-cadherin                                 Developmental Studies Hybridoma Bank                            DCAD2; RRID:[AB_528120](https://scicrunch.org/resolver/AB_528120)                1:10

  Antibody                                      mouse monoclonal anti-Fasciclin III                            Developmental Studies Hybridoma Bank                            7G10; RRID:[AB_528238](https://scicrunch.org/resolver/AB_528238)                 1:10

  Antibody                                      mouse monoclonal anti-Arm                                      Developmental Studies Hybridoma Bank                            N2-7A1; RRID:[AB_528089](https://scicrunch.org/resolver/AB_528089)               1:75

  Antibody                                      mouse monoclonal anti-Fascin (Singed)                          Developmental Studies Hybridoma Bank                            sn 7C; RRID:[AB_528239](https://scicrunch.org/resolver/AB_528239)                1:25

  Antibody                                      rabbit polyclonal anti- Phospho-Myosin Light Chain 2 (Ser19)   Cell Signaling Technology, Inc                                  \#3671; RRID:[AB_330248](https://scicrunch.org/resolver/AB_330248)               1:10

  Antibody                                      rat monoclonal anti-HA (3F10)                                  Millipore Sigma                                                 11867423001; RRID:[AB_2314622](https://scicrunch.org/resolver/AB_2314622)        1:1000

  Antibody                                      rabbit polyclonal anti-Mbs                                     [@bib59]                                                                                                                                         1:200 from Change Tan

  Antibody                                      rabbit polyclonal anti-GFP                                     Thermo Fisher Scientific                                        A11122; RRID:[AB_221569](https://scicrunch.org/resolver/AB_221569)               1:1000--1:2000

  Antibody                                      chicken polyclonal anti-GFP                                    Abcam                                                           ab13970; RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)              1:1000

  Antibody                                      rabbit polyclonal anti-PPP1R8 (NiPP1)                          Millipore Sigma                                                 HPA027452; RRID:[AB_1854490](https://scicrunch.org/resolver/AB_1854490)          1:100

  Antibody                                      Alexa Fluor 488, 568, or 647                                   Thermo Fisher Scientific                                                                                                                         1:400

  Chemical compound, drug                       Alexa Fluor 488 or 568 Phalloidin                              Thermo Fisher Scientific                                        A12379 or A12380                                                                 1:400

  Chemical compound, drug                       Phalloidin-Atto 647N                                           Millipore Sigma                                                 65906                                                                            1:400

  Chemical compound, drug                       4',6-Diamidino-2-phenylindole (DAPI)                           Millipore Sigma                                                 D9542                                                                            0.05 µg/ml

  Software, algorithm                           FIJI                                                           PMID:[22743772](https://www.ncbi.nlm.nih.gov/pubmed/22743772)                                                                                    

  Software, algorithm                           Graphpad Prism 7, Prism 8                                      <https://www.graphpad.com/>                                                                                                                      

  Software, algorithm                           Adobe Photoshop CC                                             <https://www.adobe.com/>                                                                                                                         

  Software, algorithm                           Adobe Illustrator CC 2018                                      <https://www.adobe.com/>                                                                                                                         

  Software, algorithm                           Affinity Designer 1.7.1                                        <https://affinity.serif.com/>                                                                                                                    

  Software, algorithm                           Zeiss AxioVision 4.8                                           Zeiss                                                                                                                                            

  Software, algorithm                           Zeiss ZEN 3.0                                                  Zeiss                                                                                                                                            

  Software, algorithm                           Final Cut Pro X 10.4.8                                         Apple                                                                                                                                            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Drosophila* genetics and strains {#s4-1}
---------------------------------

Crosses were generally set up at 25°C unless otherwise indicated. The *tub*-GAL80^ts^ ('tsGAL80') transgene ([@bib49]) was included in many crosses to suppress GAL4-UAS expression during earlier stages of development; these crosses were set up at 18°−22 °C to turn on tsGAL80. For *c306*-GAL4, *c306*-GAL4-tsGal80, *slbo*-GAL4, or *upd*-GAL4 tsGAL80 crosses, flies were incubated at 29°C for ≥14 hr prior to dissection to produce optimal GAL4-UAS transgene expression. *c306*-GAL4 is expressed early and more broadly in border cells, polar cells, and terminal (anterior and posterior) follicle cells ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}; [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}; [@bib81]). During oogenesis, *slbo*-GAL4 turns on later than *c306*-GAL4, and is expressed in border cells but not polar cells, as well as a few anterior and posterior follicle cells at stage 9 ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}; [Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}; [@bib81]; [@bib72]). *upd-*GAL4 is restricted to polar cells at all stages of oogenesis ([Figure 1---figure supplement 2C,H](#fig1s2){ref-type="fig"}; [@bib8]). Mosaic mutant clones of *flw* were generated using the FLP-FRT system ([@bib97]). The *flw^FP41^* FRT 19A line was crossed to *ubi*-mRFP.nls *hs*FLP FRT19A; the resulting progeny were heat shocked for 1 hr at 37°C, two times a day for 3 d, followed by 3 d at 25°C prior to fattening and dissection. Mutant clones were identified by loss of nuclear RFP signal from *ubi-*mRFP.nls.

The following *Drosophila* strains (with indicated stock numbers) were obtained from the Bloomington *Drosophila *Stock Center (BDSC, Bloomington, IN, USA): *c306*-GAL4 (3743), UAS-NiPp1.HA (23711), UAS-Pp1-87B.HA (24098), UAS-Pp1-13C.HA (23701), UAS-Pp1α−96A.HA (23700), UAS-hPPP1CC (64394), UAS-mCD8-ChRFP (27392), UAS-mCherry RNAi (35785), UAS-Pp2B-14D RNAi (25929, 40872), UAS-mts RNAi (27723, 38337, 57034, 60342), UAS-Pp4-19C RNAi (27726, 38372, 57823), UAS-CanA-14F RNAi (38966), UAS-PpD3 RNAi (57307), UAS-PpV RNAi (57765), UAS-CanA1 RNAi (25850), UAS-CG11597 RNAi (57047, 61988), UAS-rgdC RNAi (60076), UAS-Flw RNAi (38336), UAS-β-Catenin RNAi JF01252 (31305), *flw^FP41^* FRT 19A (51338), ubi-mRFP.nls hsFLP FRT19A (31418), UAS-PLCδ-PH-EGFP ('membrane GFP'; 39693), UAS-GFP.nls (4776).

The following *Drosophila* strains (with indicated stock numbers) were obtained from the Vienna *Drosophila *Resource Center (VDRC, Vienna, Austria): UAS-Pp1α−96A RNAi (v27673), UAS-Pp1-87B RNAi (v35024), UAS-Pp1-13C RNAi (v29058), UAS-Flw RNAi (v29622, v104677), UAS-Mbs RNAi (v105762), UAS-Pp2B-14D RNAi (v46873), UAS-Pp4-19c RNAi (25317), UAS-E-Cadherin RNAi (v27082, v103962), UAS-β-Catenin RNAi (v107344), UAS-α-Catenin RNAi (v20123, v107298), UAS-Sqh RNAi (v7916), fTRG Pp1α −96A (v318084), fTRG Sqh (v318484).

Other *Drosophila* strains used in this study were: *slbo*-GAL4, *slbo*-GAL4 UAS-mCD8-GFP, *upd-*GAL4;; tsGAL80, and *slbo*-LifeAct-GFP line 2M (from D. Montell, University of California, Santa Barbara, Santa Barbara, CA, USA), *flw^CPTI002264^* protein trap (line 115284, Kyoto Stock Center, Kyoto, Japan), UAS-mCherry-Jupiter (from C. Doe, University of Oregon, Eugene, OR, USA), UAS-Rac FRET ([@bib92]), UAS-Rho FRET/CyO; UAS-Rho FRET/TM6B ([@bib66]), and UAS-Flw.HA (FlyORF) ([@bib6]). The *c306*-GAL4 tsGAL80 ([@bib3]) and *c306-*GAL4 tsGAL80/FM6; UAS-NiPp1.HA/TM3 Ser stocks were created in our lab.

Female fertility test {#s4-2}
---------------------

Fertility was determined according to established methods ([@bib87]). Briefly, four *c306-*GAL4 tsGAL80/FM6; Sco/CyO (control) or *c306-*GAL4 tsGAL80/FM6; UAS-NiPP1/TM3 Ser (experimental) females were outcrossed to four *w^1118^* males. The flies were allowed to mate for 2 days followed by a 24 hr egg lay at 30 °C on fresh food medium supplemented with yeast. Adults were then removed and the progeny allowed to develop in the vial at 25 °C; the food was periodically monitored to avoid drying out. Scoring of eclosed adult progeny from each vial was performed 16--20 d after egg laying and reported as the average progeny per female.

Immunostaining {#s4-3}
--------------

Fly ovaries from 3- to 5-d-old females were dissected in Schneider's *Drosophila *Medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (Seradigm FBS; VWR, Radnor, PA, USA). Ovaries were kept whole or dissected into individual egg chambers, followed by fixation for 10 min using 4% methanol-free formaldehyde (Polysciences, Warrington, PA, USA) in 0.1 M potassium phosphate buffer, pH 7.4, or in 1X Phosphate Buffered Saline (PBS). Washes and antibody incubations were performed in 'NP40 block' (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% NP40, 5 mg/ml bovine serum albumin \[BSA\]). For α-Catenin immunostaining, dissected egg chambers were fixed for 20 min in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA, USA) in potassium phosphate buffer, pH 7.4, followed by a separate blocking step for 30 min (2% BSA in 1x PBS) prior to each antibody incubation. For p-Sqh antibody staining, ovaries were fixed for 5 min in 8% methanol-free formaldehyde. For the F-actin staining in [Figure 6](#fig6){ref-type="fig"}, the entire dissection procedure was performed in less than 10 min to preserve F-actin structures, followed by fixation in the presence of Phalloidin at 1:400 dilution; after washing off the fix, the egg chambers were incubated in Phalloidin at 1:400 for 2 h ([@bib82]).

The following primary antibodies from the Developmental Studies Hybridoma Bank (DSHB, University of Iowa, Iowa City, IA, USA) were used at the indicated concentrations: rat anti-E-Cadherin 1:10 (DCAD2), mouse anti-Fasciclin III 1:10 (FasIII; 7G10), mouse anti-Arm (β-Catenin) 1:75 (N2-7A1), concentrated rat anti-α-Catenin 1:1000 (DCAT1), mouse anti-Eyes Absent 1:100 (eya10H6), mouse anti-Lamin Dm0 1:10 (ADL67.10), and mouse anti-Singed 1:25 (Sn7C). Additional primary antibodies used were: rabbit anti-Phospho-Myosin Light Chain 2 (Ser19) 1:10 (\#3671, Cell Science Technology, Danvers, MA, USA), rat anti-HA 1:1000 (11867423001, Millipore Sigma, Burlington, MA, USA), rabbit anti-Mbs 1:200 (from C. Tan, University of Missouri, Columbia, MO, USA); rabbit anti-GFP polyclonal 1:1000-1:2000 (A-11122, Thermo Fisher Scientific), chicken anti-GFP polyclonal 1:1000 (ab13970, Abcam, Cambridge, MA, USA), rabbit anti-PPP1R8 (NiPP1) polyclonal 1:100 (HPA027452, Millipore Sigma), rat anti-Slbo 1:2000 (from P. Rørth, Institute of Molecular and Cell Biology, Singapore). Alexa Fluor 488, 568, or 647 secondary antibodies (Thermo Fisher Scientific) were used at 1:400 dilution. Alexa Fluor Phalloidin (488 or 568; Thermo Fisher Scientific) and Phalloidin--Atto 647N (Millipore Sigma) were used at 1:400 dilution. 4',6-Diamidino-2-phenylindole (DAPI, Millipore Sigma) was used at 0.05 µg/ml. Egg chambers were mounted on slides with Aqua-Poly/Mount (Polysciences) or FluorSave Reagent (Millipore Sigma) for imaging.

Microscopy, live time-lapse imaging, and FRET {#s4-4}
---------------------------------------------

Images of fixed egg chambers were acquired with an upright Zeiss AxioImager Z1 microscope and Apotome.2 optical sectioning, or on a Zeiss LSM 880 confocal microscope with or without Airyscan (KSU College of Veterinary Medicine Confocal Core), using either a 20 × 0.75 numerical aperture (NA) or 40 × 1.3 NA oil-immersion objective.

Live time-lapse imaging was performed as described ([@bib64]; [@bib15]). Briefly, ovarioles were dissected in room-temperature sterile live imaging media (Schneider's *Drosophila *Medium, pH 6.95, with 15--20% FBS). Fresh live imaging media, supplemented with 0.2 µg/ml bovine insulin (Cell Applications, San Diego, CA, USA), was added to the sample prior to mounting on a lumox dish 50 (94.6077.410; Sarstedt, Newton, NC, USA). Time-lapse videos were generally acquired at intervals of 2--3 min for 3--6 hr using a 20 × Plan Apochromat 0.75 NA objective, a Zeiss Colibri LED light source, and a Zeiss Axiocam 503 mono camera. The LED light intensity was experimentally adjusted to maximize fluorescence signal and to minimize phototoxicity of the live sample. Live time-lapse Sqh-GFP imaging was performed on a Zeiss LSM 880 confocal, as described ([@bib15]), with a 40 × 1.2 NA water-immersion objective using an interval of 1 min for up to 20 min total time and a laser setting of 1.5%. Imaging gain and other acquisition parameters were the same, except that the range of *z*-stacks varied slightly depending on the sample. In some cases, multiple *z*-stacks were acquired and merged in Zeiss AxioVision, Zeiss ZEN 2, or FIJI ([@bib78]) to produce a single, in-focus time-lapse video.

FRET images (Rac FRET, Rho FRET) of live cultured egg chambers were acquired with a Zeiss LSM710 microscope essentially as described ([@bib92]). A 40 × 1.3 NA oil inverted objective was used to capture single high-resolution stationary images. A 458 nm laser was used to excite the sample. CFP and YFP emission signals were collected through channel I (470--510 nm) and channel II (525--600 nm), respectively. The CFP and YFP channels were acquired simultaneously for most experiments. Sequential acquisition of CFP and YFP channels was tested but produced the same result as simultaneous acquisition.

Image processing and data analysis {#s4-5}
----------------------------------

Image measurements and editing were performed using Zeiss ZEN or FIJI ([@bib78]). Analyses of live border cell migration time-lapse videos was performed using Zeiss ZEN software. The migration speed was calculated from the duration of border cell movement. Protrusion quantification was performed as described ([@bib76]). Briefly, a circle was drawn around the cell cluster, and extensions greater than 1.5 µm outside the circle were defined as protrusions ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Protrusions were classified as directed to the front (0°−45° and 0°−315°), side (45°−135°and 225°−315°), or back (135°−225°), based on their positions within the cluster. The first 1 hr of each video was used for protrusion quantification.

To determine the number of cells per cluster, egg chambers were stained for the nuclear envelope marker Lamin, the DNA stain DAPI, and the cell membrane marker E-Cadherin. Only clusters that had delaminated, moved forward, and had any detectable E-Cadherin were imaged. This allowed confidence that the scored cells were border cells. Acquisition of *z*-stacks that encompassed the entire cluster (border cells and polar cells) were defined by nuclear Lamin signal. This was followed by manual counting of the nuclei from the resulting images.

The circularity of border cells was measured in FIJI. Individual border cells were outlined manually based on the PLCδ-PH-GFP signal using the 'Freehand Selections' tool. Within the 'Set Measurements' analysis tool, 'shape descriptors' was selected, followed by the 'Measure' function, which provided a measurement of circularity. A value of 1.0 indicates a perfect circle, whereas 0.0 represents an extremely elongated shape.

Measurements of E-Cadherin and β-Catenin intensity at cell--cell junctions were performed on egg chambers that were stained using identical conditions. Samples were imaged with a 40 × 1.3 NA oil objective. Identical confocal laser settings were used for each channel and a full *z*-stack of the cluster was produced. Images were then subjected to 3D reconstruction through the '3D Project' function in FIJI. Border cell-border cell (BC-BC) contacts and nurse cell-nurse cell (NC-NC) contacts were manually identified, a line (width set as 6) drawn, and mean fluorescence intensity across the line was obtained using the 'measure' tool. A ratio of BC-BC intensity versus NC-NC intensity was calculated to normalize protein levels.

To measure colocalization between Mbs and Flw, or Mbs and Pp1α−96A, the 'RGB Profiler' FIJI plugin was used. After converting the image to RGB, a line was drawn across the whole border cell cluster to generate the image intensity plot. The localization patterns of F-actin and Mbs with Pp1α−96A-GFP and Flw-YFP were measured through the 'Analyze \>Plot Profile' function in FIJI. A line was drawn across the border cells and polar cells and the pixel intensity value was obtained across the line. The values for each channel were normalized to the highest pixel value, and a scatter plot showing F-actin and DAPI was generated in Microsoft Excel.

For Rho-FRET and Rac-FRET, the CFP and YFP images were first processed in ImageJ. A background region of interest was subtracted from the original image. The YFP images were registered to CFP images using the TurboReg plugin. The Gaussian smooth filter was then applied to both channels. The YFP image was thresholded and converted to a binary mask with the background set to zero. The final ratio image was generated in MATLAB, during which only the unmasked pixels were calculated as described ([@bib92]).

Figures, graphs, and statistics {#s4-6}
-------------------------------

Figures were assembled in Adobe Photoshop CC. Illustrations were created in Affinity Designer (Serif, Nottingham, United Kingdom). Videos were assembled in Zeiss AxioVision 4.8, Zeiss ZEN 2, or FIJI. Graphs and statistical tests were performed using GraphPad Prism 7 or Prism 8 (GraphPad Software, San Diego, CA, USA). The statistical tests and *p* values are listed in the figure legends.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

How groups of cells migrate directionally as cohesive clusters is still not well understood. In this paper the authors demonstrate that in the fly ovary the Pp1 phosphatase plays a crucial role in regulating cell delamination, migration and cohesion of polar cells. The authors performed a detailed analysis and quantification of the phenotypes resulting from knockdown of different subunits. The resulting phenotypes are quite striking with the border cell collective falling apart, rounding of the cells and frequent failure to reach the oocyte. The paper shows that via different subunits Pp1 controls adherence of the cells to the cluster as well as cell shape, thereby regulating collective cell versus single cell behaviors.

**Decision letter after peer review:**

Thank you for submitting your work \"Protein Phosphatase 1 activity controls a balance between collective and single cell modes of migration\". Your article has been reviewed by three reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Utpal Banerjee as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this manuscript by Chen et al., the authors discovered that protein phosphatase 1 (Pp1) globally controls the organization, cohesion, and coordination of *Drosophila* border cells. Specifically, they show that Pp1 activity, mediated through distinct phosphatase complexes such as myosin phosphatase is as a critical regulator of collective cell versus single cell behaviors. To test possible functions of phosphatases in border cell migration the authors screened selected serine-threonine phosphatases that are expressed during oogenesis via RNAi or the inhibitor NiPp1. The authors performed a detailed analysis and quantification of the phenotypes resulting from knockdown of different subunits. The resulting phenotypes are quite striking with the border cell collective falling apart, rounding of the cells and frequent failure to reach the oocyte. Using a candidate gene approach the authors show that cadherin-catenin expression is downregulated and that loss of cadherin-catenin complex members causes similar phenotypes as loss of Pp1. In addition, rounding of cell shapes suggested alterations in the cortical cytoskeleton, which is supported by loss of polarized F-actin and Myo-II.

While the manuscript is interesting, beautifully illustrated and accompanied by a scholarly written discussion, the reviewers feel that some additional experiments will lead to a better mechanistic understanding of the function of Pp1.

1\) The temporal dynamics of the phenotypes needs to be described in more detail. Specifically, the authors should clarify phenotypes in reference to the different stages of migration and investigate if the different Pp1 catalytic subunits possess distinct, stage-specific roles (e.g. delamination vs. active migration) or if all of their functions are overlapping.

2\) In addition, the authors conclude that Pp1 globally coordinates the collective behaviors of border cells, from adhesion of cells within the cluster, to formation of migratory protrusions, formation of proper cell shapes, and efficient group motility. From the study it is unclear if these phenotypes are directly controlled by Pp1 or if some of them could be, for example, secondary to the loss of adhesion or the mis-localization of Myo-II. The authors mention in the Discussion section that Myo-II and cadherin-catenin complexes possess dynamic interactions that influence stability of cell-cell junctions, suggesting that the adhesion defect could be secondary to the defect in Myo-II distribution.

It would be helpful to already mention and test such possible interactions in the result section. The authors should determine how F-actin, Myo-II and cadherin-catenin complexes are localized in the respective RNAi experiments.

3\) The results pertaining to p-Sqh/Myosin and *Mbs*-RNAi, in particular, are less convincing and need to be strengthened (Figure 7) as the phenotypes were not very clear (e.g. Video 14). Likewise, Video 16 does not convincingly support the conclusion that sqh:GFP is more uniform, "especially at contacts between some border cells".

"Pp1c border cells followed the normal migratory path down the center of the egg chamber between nurse cells, even if when cells broke off..." This does not seem to be the case in Video 7. Please, also indicate how many videos were obtained for each experiment.

4\) Furthermore, while this study does a nice job of putting a lot of data into context, some results need to be more clearly explained in the context of the field, to clarify new results from those that have been previously documented- particularly with respect to the previous results of the Mbs subunit of PP1 (Aranjuez et al., 2016) and if such drastic loss of border cell cohesion has been previously observed after any other experimental manipulations.

10.7554/eLife.52979.sa2

Author response

> 1\) The temporal dynamics of the phenotypes needs to be described in more detail. Specifically, the authors should clarify phenotypes in reference to the different stages of migration and investigate if the different Pp1 catalytic subunits possess distinct, stage-specific roles (e.g. delamination vs. active migration) or if all of their functions are overlapping.

We agree that this is an important point. Delamination (also called "detachment") from the follicular epithelium is an essential step in border cell collective migration, as it controls movement of the cohesive cluster out of the epithelium and into the egg chamber proper. We have now re-analyzed the *Pp1* mutant (RNAi) phenotypes from our previously acquired data, both in fixed samples and in live time-lapse imaging, which is now shown in Figure 3E and Figure 3---figure supplement 1A.

In fixed samples, we asked if the border cells delaminated from the follicular epithelium and partially migrated (delaminated, but stopped anywhere along the migration pathway), delaminated and reached the oocyte ("complete" migration), or did not delaminate/migrate ("no migration"). The majority of Pp1c-inhibited border cells delaminated but stopped along the migration pathway. However, in the case of *Pp1α-96A-*RNAi border cells, \~15% of border cells did not migrate (*p* \< 0.001) suggesting that at least this Pp1c subunit has a role in delamination (Figure 3E). *flw* mosaic clones also have split border cells that do not migrate (Figure 3J). The other two Pp1c subunits had a few border cells fail to delaminate/migrate, but this was not statistically significant (Figure 3E).

To confirm that *Pp1c* is required for delamination, we analyzed the live time-lapse videos for delamination by the end of imaging. Because these clusters often split (e.g. Figure 3B-D,F), we analyzed each individual "part", or small group of dissociated border cells, within each video. As with the fixed samples, *Pp1α-96A-*RNAi live border cells had a significant fraction of border cells that did not delaminate during the video, compared to *Pp1-87B* or *Pp1-13C* RNAi in which most border cells delaminated (Figure 3---figure supplement 1A). This is also supported by Video 8, where some *Pp1α-96A-*RNAi border cells visibly had trouble delaminating and did not leave the epithelium during imaging. These data are now described in the text subsection "Pp1c genes are required for border cell cluster migration and cohesion".

Both *Pp1α-96A*-RNAi and *flw* mosaic clones result in more delamination defects (no migration) than that observed with knockdown of the other two *Pp1c* subunits. These results suggest roles for Flw and Pp1α-96A during delamination, with all Pp1c subunits required to keep border cells together and efficiently migrate once the clusters delaminate. However, due to potential partial knockdown by RNAi we cannot completely rule out overlapping roles for the other two Pp1c subunits during delamination. Moreover, we observed full rescue of NiPp1 phenotypes by human PPP1CC, a Pp1c ortholog with high similarity to all four *Drosophila* catalytic subunits (Figure 2G,H). Thus, these data agree with known overlapping/redundant roles for Pp1c during *Drosophila* development (Kirchner et al., 2007).

We edited the text to reflect these findings: "NiPp1 expression results in more severe phenotypes than RNAi knockdown, or loss, of individual Pp1c genes, at least with respect to migration and cluster cohesion, suggesting that Pp1c subunits have both distinct and overlapping functions. In particular, Pp1α-96A and Flw appear to function in border cell delamination, whereas all four subunits likely promote migration and cluster cohesion."

> 2\) In addition, the authors conclude that Pp1 globally coordinates the collective behaviors of border cells, from adhesion of cells within the cluster, to formation of migratory protrusions, formation of proper cell shapes, and efficient group motility. From the study it is unclear if these phenotypes are directly controlled by Pp1 or if some of them could be, for example, secondary to the loss of adhesion or the mis-localization of Myo-II. The authors mention in the Discussion section that Myo-II and cadherin-catenin complexes possess dynamic interactions that influence stability of cell-cell junctions, suggesting that the adhesion defect could be secondary to the defect in Myo-II distribution.
>
> It would be helpful to already mention and test such possible interactions in the result section. The authors should determine how F-actin, Myo-II and cadherin-catenin complexes are localized in the respective RNAi experiments.

This is an important point. As suggested, we determined if the phenotypes observed with Pp1-inhibition are secondarily due to decreases in the cadherin-catenin complex. We analyzed F-actin and active Myo-II (p-Sqh) in *E-Cad-*RNAi and *β-Cat-*RNAi border cells (Figure 6---figure supplement 2). Additionally, we analyzed the dynamics of migrating border cells when *α-Catenin* was knocked down by RNAi (Figure 5---figure supplement 1F-J). Moreover, Montell and colleagues recently examined Sqh protein dynamics in live *E-cad*-RNAi border cells (Mishra et al., 2019).

First, Pp1-inhibition resulted in very high F-actin with elevated peak fluorescence signals at the cell cortex of each individual border cell (Figure 6E,E',G). In contrast, *cadherin-catenin*-RNAi resulted in uniform (and possibly lower) F-actin levels across the entire cluster (Figure 6---figure supplement 2B-C',F,G). Second, the effects on Sqh/Myo-II were also different between NiPp1 and *E-Cad*/*β-Cat-*RNAi. Unlike control, p-Sqh was no longer enriched at the cluster periphery in *E-Cad-*RNAi or *β-Cat-*RNAi border cells (Figure 6---figure supplement 2I-K). This is in contrast to NiPp1 border cells, in which p-Sqh is localized both at the cluster periphery and between border cells (Figure 7A-C). Please note that we were unable to obtain confocal images for p-Sqh in control RNAi, *E-Cad-*RNAi, and *β-Cat-*RNAi, because the K-State Vet-Med Confocal Core shut down due to COVID-19. The images in Figure 6---figure supplement 2I-K were instead taken on our widefield fluorescent microscope. Because we did not include a membrane marker in these experiments, we did not quantitate the ratio of p-Sqh at different cell-cell contacts within the cluster. Consistent with our results with p-Sqh in *E-Cad-*RNAi and *β-Cat-*RNAi, however, Mishra et al., 2019, similarly observed overall reduction in cortical Sqh-mCherry protein distribution and levels in live *E-Cad-*RNAi border cells compared to control.

As suggested, we analyzed E-cadherin and β-Catenin in *sqh*-RNAi (Figure 6---figure supplement 3), allowing us to more directly determine how much Myo-II regulates the cadherin-catenin complex in border cells. We found little difference in E-cadherin levels at BC-BC cell contacts in *sqh*-RNAi compared to control (Figure 6---figure supplement 3A-B'',E), although there was slightly elevated β-Catenin in *sqh-*RNAi border cell clusters (Figure 6---figure supplement 3C-D'',F). We also analyzed F-actin levels and distribution in *sqh*-RNAi (Figure 6---figure supplement 2D,D',H). We found that F-actin was present but no longer enriched at the periphery of *sqh-*RNAi border cell clusters (Figure 6---figure supplement 2D,D',H). Thus, data from *sqh-*RNAi suggest that Myo-II is not a major regulator of the cadherin-catenin complex in border cells. Further, Myo-II may normally elevate F-actin levels at the cluster periphery.

We have added a section to the Results to describe these new findings, "Interplay between cadherin-catenin adhesion and actomyosin dynamics". Our results support a more direct role for Pp1 activity in controlling collective versus single cell dynamics of actomyosin and cadherin-catenin in border cells. We favor a model in which there are distinct Pp1 phosphatase complexes that regulate Myo-II versus the cadherin-catenin complex as described in the Discussion.

> 3\) The results pertaining to p-Sqh/Myosin and Mbs-RNAi, in particular, are less convincing and need to be strengthened (Figure 7) as the phenotypes were not very clear (e.g. Video 14).

We repeated the p-Sqh staining, using the same fixation and antibody staining protocols we used in our prior publication (Majumder et al., 2012), which resulted in consistent staining (see also Materials and methods). Moreover, we drove expression of NiPp1 using the early GAL4, *c306-*GAL4, along with a membrane-GFP (PLCδ-PH-EGFP). This allowed us to better quantify the relative ratio of p-Sqh at cell membrane contacts between border cells ("BC-BC") and at contacts between border cells and nurse cells ("BC-NC"). We imaged many of these samples using the Zeiss Airyscan near-super resolution microscope, while others were imaged on our standard widefield fluorescent microscope. Please note that we were unable to access all of the Airyscan data after the K-State Confocal Facility closed due to COVID-19, but data were consistent no matter the acquisition method.

Border cells inhibited for Pp1 (NiPp1-expressing) exhibited high levels of p-Sqh at BC-BC contacts rather than just at the cluster periphery (BC-NC; Figure 7A-C; Videos 14-17 for Sqh-GFP). We measured the relative ratio of BC-NC p-Sqh to BC-BC p-Sqh. In control clusters, this ratio was \~1.10, indicating higher p-Sqh at BC-NC junctions. In NiPp1 clusters, the ratio was \~0.95, indicating an increase in p-Sqh at BC-BC junctions along with enriched p-Sqh at BC-NC junctions.

We edited the text: "Control border cells exhibited p-Sqh signal primarily at the cluster periphery ("BC-NC" contacts; Figure 7A-A''). This pattern of p-Sqh closely resembles the pattern of Sqh-GFP in live wild-type border cells (Figure 6H-H""') (Aranjuez et al., 2016; Majumder et al., 2012; Plutoni et al., 2019; Zeledon et al., 2019). NiPp1 border cells, however, had high levels of p-Sqh distributed throughout the cluster including at internal BC-BC contacts (Figure 7B-B''), similar to Sqh-GFP in live NiPp1 border cells (Figure 6I-I""'). We measured the relative ratio of p-Sqh fluorescence intensity at BC-NC contacts versus BC-BC contacts in control and NiPp1 border cell clusters (Figure 7C). Control border cells had a higher p-Sqh ratio than NiPp1, indicating more p-Sqh signal at BC-NC contacts. These data support the idea that Pp1 inhibition elevates Myo-II activation within single border cells."

For *Mbs* RNAi, we now show two examples of typical phenotypes in Figure 7D-F. In some cases, we observed splitting of the cluster, with one group staying at the anterior and the other group completing migration to the oocyte (Figure 7E), similar to what we observed with *flw* mosaic mutant clusters (*see* Figure 3H-H'' and Figure 3---figure supplement 1B-B''). In other cases, we observed both splitting along the migration path and migration defects (Figure 7F). We agree that *Mbs* RNAi migration and cohesion defects are not as penetrant as those observed with NiPp1 expression or *Pp1c* RNAi (Figure 7G,H compared to Figures 1I,J and 3E,F).

The milder phenotypes caused by *Mbs* RNAi could be due to incomplete knockdown by the *Mbs* RNAi transgene, even though Mbs protein levels were reduced (Figure 7---figure supplement 1K-L''). Alternatively, the Pp1c/Mbs myosin phosphatase complex may be only one of multiple Pp1 complexes required in border cells. Although we believe that a major target of Pp1 activity is Myo-II, we also think it very likely that multiple Pp1 complexes regulate F-actin and adhesion and possibly other to-be-identified phosphorylated substrates in border cells (*see* Discussion).

We revised the text to reflect these results: "The phenotypes observed with Mbs-RNAi are milder than those observed with Pp1-inhibition (either NiPp1 or Pp1c-RNAi; compare to Figures 1I and 3E). This could be due to incomplete knockdown by Mbs-RNAi, although we observed significant decreases in the levels of endogenous Mbs (Figure 7---figure supplement 1K-L"). Alternatively, myosin phosphatase, through a complex of Mbs/Pp1c, could be one of multiple Pp1 complexes required for border cell cluster migration and cohesion (see Discussion). Nonetheless, these findings indicate that myosin phosphatase, a specific Pp1 complex, helps promote the normal cell morphology and collective cohesion of border cells, in addition to facilitating the successful migration of the border cells."

> Likewise, Video 16 does not convincingly support the conclusion that sqh:GFP is more uniform, "especially at contacts between some border cells".

Because the previous videos of Sqh-GFP were acquired on a single focal plane to minimize phototoxicity while still having high resolution, we acknowledge that the videos may not have been clear. Therefore, we obtained new videos using full *z-*stacks. We reduced the laser intensity, used a faster frame rate, and further opened the pinhole, all of which achieved a better signal-to-noise ratio and faster acquisition time while still minimizing phototoxicity (Videos 14-17). We imaged for 20 min. Additionally, to more clearly show localization of Sqh-GFP in the cluster, in the new videos we included full 3D *z-*stack reconstructions of the border cell cluster at the start and end of imaging, along with the time-lapse video showing a single focal plane.

The new videos more clearly show the differences in Sqh-GFP localization in control versus Pp1-inhibited border cells. In NiPp1 border cells, Sqh-GFP no longer localizes to the cluster periphery, but is now found around each border cell. However, rather than being "more uniform" around each NiPp1-expressing border cell as stated in the previous version of the manuscript, we now find that Sqh-GFP is enriched in highly dynamic foci at the cell membranes of individual NiPp1-expressing border cells (Videos 15 and 17). These dynamic Sqh-GFP foci resemble those of control clusters (Videos 14 and 16), and are consistent with previous studies (Aranjuez et al., 2016; Combedazou et al., 2017; Majumder et al., 2012; Mishra et al., 2019). These results further support the idea that NiPp1-expressing border cells function more as single cells rather than as a collective.

These data are now shown in Video 14 (control early migration), Video 15 (NiPp1 early migration), Video 16 (control mid-migration), Video 17 (NiPp1 mid-migration), Figure 6H-I''''', and Figure 6---figure supplement 1.

We edited the text: "In NiPp1 border cells, however, Sqh-GFP was now present at cortical cell membranes in dynamic foci surrounding each border cell (or sub-cluster) rather than at the entire cluster periphery, both during early migration (Figure 6---figure supplement 1B-B""'; Video 15) and at mid-migration stages (Figure 6I-I""'; Video 17). Thus, inhibition of Pp1 converts collectively polarized F-actin and Myo-II to that characteristic of single migrating cells. As a result, individual border cells now have enriched and dynamic actomyosin localization consistent with elevated cortical contractility in single cells rather than at the collective level."

> "Pp1c border cells followed the normal migratory path down the center of the egg chamber between nurse cells, even if when cells broke off..." This does not seem to be the case in Video 7.

We occasionally observed off-track migration, such as in this Video (now Video 8) and in some fixed samples (e.g. Figure 3C). However, the majority of Pp1-inhibited border cells stayed on the normal pathway, or very close to the normal pathway down the center of the egg chamber (Videos 2-4, 7, 9, 10). This is in contrast to mutants that disrupt directional migration, such as loss of the guidance receptors PVR and EGFR (Duchek et al., 2001), ectopic guidance ligands (McDonald et al., 2003), or loss of the cadherin-catenin complex (e.g. Figure 4B,D; Cai et al., 2014; although note that in Video 11, this example of *α-Cat-RNAi* border cells appears to be "on-track" during the imaging).

We have edited the text to reflect this: "The majority of NiPp1 and Pp1c RNAi border cells followed the normal migratory pathway down the center of the egg chamber between nurse cells, even when cells broke off from the main cluster (Figures 1H, L-L" and 3B-D; Videos 2-5, 7-10)."

> Please, also indicate how many videos were obtained for each experiment.

The numbers of videos for each experiment/genotype are now stated in all of the figure legends and/or video legends.

> 4\) Furthermore, while this study does a nice job of putting a lot of data into context, some results need to be more clearly explained in the context of the field, to clarify new results from those that have been previously documented- particularly with respect to the previous results of the Mbs subunit of PP1 (Aranjuez et al., 2016)

The focus of our previous studies of myosin phosphatase (Mbs) was on delamination, migration, and cluster shape (Aranjuez et al., 2016; Majumder et al., 2012). Dissociation of clusters was observed with *Mbs-*RNAi, similar to NiPp1, but was not quantified at the time (Aranjuez et al., 2016). Because the focus of the Aranjuez et al., 2016, study was on overall cluster morphology, rather than cohesion, we had not included these data.

We state this in the text: "Previously, we found that Mbs was required for border cell cluster delamination from the epithelium and cell shape (Aranjuez et al., 2016; Majumder et al., 2012), although cluster cohesion had not been explicitly assessed."

In the current study we re-assessed the phenotypes caused by *Mbs-*RNAi, as shown in Figure 7D-H. While *Mbs-*RNAi only mildly disrupts migration, we observed significant dissociation of Mbs-deficient border cell clusters. While our manuscript was in preparation, Montell and colleagues published a study showing that expression of an activated form of Sqh (Sqh-^E20E21^) causes border cells to round up and dissociate from the cluster (Mishra et al., 2019). However, because Mishra et al., 2019, did not report the penetrance of these phenotypes, we cannot completely compare their results to what we observe with Pp1-inhibition. Likewise, we and others previously found that constitutively-activated Rho (Rho^V14^) disrupts border cell shape similar to Pp1-inhibition, with rounding of border cells and high F-actin and p-Sqh at individual border cell membrane cortices (Aranjuez et al., 2016; Combedazou et al., 2017; Mishra et al., 2019). Nonetheless, these data support our findings, as loss of myosin phosphatase (*Mbs-*RNAi) results in elevated p-Sqh (activated Myo-II) in border cells (Majumder et al., 2012). Thus, at least some of the phenotypes caused by Pp1-inhibition are due to loss of myosin phosphatase and high p-Sqh (activated Myo-II) around individual border cells (Figure 7A-C).

We have added this information to the Discussion: "Myosin phosphatase-depleted border cells, which have elevated phosphorylated Sqh and thus active Myo-II (Majumder et al., 2012), are highly contractile, round up, and fall off the cluster. In support of this idea, overexpression of a phosphorylation mutant form of Sqh (Sqh^E20E21^), which mimics activated Myo-II, caused border cells to similarly round up and separate from the cluster (Mishra et al., 2019)."

> and if such drastic loss of border cell cohesion has been previously observed after any other experimental manipulations.

Such drastic loss of border cell cohesion has only been observed when E-cad was knocked down solely in polar cells, where it was reported that \~70% of clusters with *E-cad-*RNAi in polar cells are split (Cai et al., 2014). In the published literature, most cluster cohesion defects appear to be milder, with only a few border cells falling off the cluster or the cluster spreading out but not fully separating (Cai et al., 2014; Llense and Martín-Blanco, 2008; Melani et al., 2008; Raza et al., 2019). Interestingly, in each of these cases, adhesion is disrupted by loss of the respective gene. For example, the work by Raza et al., 2019, identified genes that co-evolve with E-cadherin and whose knockdown regulates cell-cell adhesion. The most severe phenotypes observed by RNAi of these genes was \~35% cluster dissociation (*Raskol-*RNAi), although the number of dissociated sub-clusters or "parts" was not reported (Raza et al., 2019). Knockdown of *Raskol* decreased levels of E-cadherin at BC-BC contacts, likely accounting for the cohesion defects. Our studies on Pp1 function found \~90% dissociated of NiPp1 clusters, with \~40% of egg chambers displaying more than 3 border cell parts. Inhibition of Pp1 thus appears to be more severe than those reported in previous studies, possibly due to Pp1 having multiple downstream targets.

To provide better context to our results, we now discuss similarities and differences between our results and previously published studies in the Discussion, paragraph five.
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